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Neurogenesis in the brain of Xenopus laevis continues throughout larval stages of development. We
developed a 2-tier screen to identify candidate genes controlling neurogenesis in Xenopus optic tectum
in vivo. First, microarray and NanoString analyses were used to identify candidate genes that were dif-
ferentially expressed in Sox2-expressing neural progenitor cells or their neuronal progeny. Then an
in vivo, time-lapse imaging-based screen was used to test whether morpholinos against 34 candidate
genes altered neural progenitor cell proliferation or neuronal differentiation over 3 days in the optic
tectum of intact Xenopus tadpoles. We co-electroporated antisense morpholino oligonucleotides against
each of the candidate genes with a plasmid that drives GFP expression in Sox2-expressing neural pro-
genitor cells and quantiﬁed the effects of morpholinos on neurogenesis. Of the 34 morpholinos tested, 24
altered neural progenitor cell proliferation or neuronal differentiation. The candidates which were tagged
as differentially expressed and validated by the in vivo imaging screen include: actn1, arl9, eif3a, elk4,
ephb1, fmr1-a, fxr1-1, fbxw7, fgf2, gstp1, hat1, hspa5, lsm6, mecp2, mmp9, and prkaca. Several of these
candidates, including fgf2 and elk4, have known or proposed neurogenic functions, thereby validating our
strategy to identify candidates. Genes with no previously demonstrated neurogenic functions, gstp1,
hspa5 and lsm6, were identiﬁed from the morpholino experiments, suggesting that our screen suc-
cessfully revealed unknown candidates. Genes that are associated with human disease, such as such as
mecp2 and fmr1-a, were identiﬁed by our screen, providing the groundwork for using Xenopus as an
experimental system to probe conserved disease mechanisms. Together the data identify candidate neuro-
genic regulatory genes and demonstrate that Xenopus is an effective experimental animal to identify and
characterize genes that regulate neural progenitor cell proliferation and differentiation in vivo.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The control of cell proliferation and differentiation is essential
for proper development of the central nervous system (CNS). At
early stages of CNS development, neural stem cells divide symme-
trically to expand the neural stem cell pool (Götz and Huttner,
2005; Hardwick and Philpott, 2014). Neural stem cells change fate
and undergo asymmetric regenerative divisions to generate both
neural stem cells and neurons, which then organize into nascent
circuits. Further cell fate changes occur when neural stem cells
become quiescent or exit the cell cycle and differentiate into either
neurons or astrocytes (Encinas et al., 2006). These cell fate decisionsInc. This is an open access article uare essential events that control the patterning of the developing
brain and ultimately affect brain function (Geschwind and Rakic,
2013; Kriegstein et al., 2006). Recent work has demonstrated that
neurogenic cell fate decisions are inﬂuenced by the local environ-
ment and neural circuit activity (Alvarez-Buylla et al., 2008; Best-
man et al., 2012; Conover and Notti, 2008; Encinas et al., 2006;
Giachino and Taylor, 2009; Holmes, 2009; Sharma and Cline, 2010;
Vergano-Vera et al., 2009), suggesting that an in vivo screen may
reveal novel candidate neurogenic regulators.
The Xenopus laevis tadpole is ideally suited to screen for can-
didate neurogenic genes. Cell proliferation continues throughout
the development of the nervous system in Xenopus. In the visual
system, for example, new neurons are generated in the optic tec-
tum throughout larval development and integrate into the devel-
oping retinotectal circuit. Because the tadpole is transparent at
early stages of development, in vivo time-lapse confocal imaging ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Harvest pSox2-bd::GFP Cells
►Dissect midbrains and dissociate cells.
►Harvest isolated pSox2-bd::GFP-expressing cells and freeze.
►Repeat and pool samples to yield ~1000-2000 cells per condition.
►Separate samples for each experimental condition into 5 replicates.
Rearing Conditions 
dpf
stage
6 987
494846 47
5 10
Mature Neurons
Quiescent Neural Progenitor Cells (qNPC)
Active Neural Progenitor Cells (aNPC)
Active Neural Progenitor Cells (aNPCvd)
Immature Neurons
Enriched Cell Population
Rearing Conditions to Enrich for Proliferating or 
Differentiated Cells
Group 30 tadpoles for each 
experimental conditionElectroporate 
pSox2-bd::GFP
Microarray Hybridization
►Hybridize to the Xenopus laevis GeneChip 2.0 (Affymetrix). 
►Wash and read chips as suggested by Affymetrix.
►Final yield: 5 .cel files for each experimental condition.
RNA Isolation, Purification & Amplification
►Isolate total RNA.
►Amplify using NuGen
►Assess quality using Agilent Bioanalyzer.
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observations of the fates of the proliferating cell population
(Bestman et al., 2012). We developed an in vivo screen to identify
candidate genes affecting cell proliferation or differentiation in
Xenopus tectum. First, we used cDNA microarrays and NanoString
analysis to identify transcripts that are differentially expressed
between neural progenitor cells (NPCs) and their progeny. Next, a
subset of gene candidates was evaluated in a secondary screen:
after morpholinos were electroporated to knockdown candidates,
differences in proliferation or differentiation were determined by
in vivo time-lapse imaging of NPCs and their neuronal progeny.
These analyses identiﬁed a diverse range of candidate neurogenic
genes that modulate proliferation and neuronal differentiation
in the brain, thus implicating a variety of regulatory pathways
affecting neurogenesis. Mechanisms controlling cell proliferation
and differentiation are highly conserved across evolution (Cha-
pouton et al., 2007; Cheung et al., 2007; Kriegstein et al., 2006;
Molnar, 2011; Pevny and Nicolis, 2010; Pierfelice et al., 2011) and
are fundamental for the evolution of brain structures (Charvet and
Striedter, 2011; Finlay et al., 1998). Therefore, identiﬁcation of
regulatory mechanisms affecting neurogenesis in the Xenopus CNS
will likely provide insights into neural stem cell fate decisions
during the development of the CNS and during adult neurogenesis.
Furthermore, a deeper understanding of the underlying mechan-
isms controlling the balance between cell proliferation and dif-
ferentiation may also direct the discovery of potential therapeutics
for brain injury, developmental disorders, and interventions to
replace cells lost by injury and neurodegenerative diseases.aNPC
vs
Mature Neurons
aNPCvd
vs
Immature Neurons
aNPC
vs
qNPCs
Microarray and Bioinformatic Comparisons 
►Process data.
Fig. 1. Flow diagram of the protocols for animal rearing, cell isolation, RNA pre-
paration and microarray hybridization. At stage 46 or 48, tadpoles were electro-
porated with a GFP-expression construct and placed in one of three visual
experience conditions: normal 12 h light:12 h dark conditions; visual deprivation
(vd), or enhanced visual experience. These rearing conditions produced 5 cell
groups: active NPCs (aNPCs), Mature Neurons, Immature Neurons, Active NPCs
isolated from visually-deprived tadpoles (aNPCvd), and quiescent NPCs (qNPCs). See
text for details. GFPþ cells were harvested from dissociated midbrains and RNA
was isolated and prepared for microarrays. The bottom panel shows which samples
were compared by microarray analysis to identify differentially expressed genes
that might be involved in cell proliferation and neurogenesis.Results
A screen for differentially expressed transcripts from neural pro-
genitor cells and differentiated neurons
The goal of our study was to identify and evaluate candidate
neurogenic genes based on a 2-tiered screen in which microarray
and NanoString analyses were used to identify transcripts that
might regulate cell proliferation and differentiation in the brain,
followed by an in vivo, time-lapse imaging-based screen to test
selected candidate genes. We focused our attention on the tadpole
optic tectum, where we had established experimental strategies to
enrich for actively dividing NPCs, differentiated neurons or quies-
cent progenitors based on the normal time course of optic tectal cell
development and the effects of visual experience (Bestman et al.,
2012; Sharma and Cline, 2010). We labeled NPCs and their progeny
with a construct that drives GFP reporter expression in Sox2-
expressing cells, called pSox2-bd::GFP (Bestman et al., 2012) and
isolated GFP-labeled cells that are enriched for active or quiescent
NPCs or differentiated neurons (Fig. 1). Our previous work showed
that 1 day after transfecting the optic tectum of stage 46 animals
with pSox2-bd::GFP, the majority of the GFP-expressing cells are
mitotically active NPCs and by three days after transfection, most
GFP-expressing cells have differentiated into neurons (Bestman
et al., 2012). Pulse-chase labeling tectal progenitors with CldU also
demonstrated that the majority of NPCs differentiate into neurons
over a two-day period (Sharma and Cline, 2010). Furthermore, rates
of cell proliferation in the optic tectum decrease signiﬁcantly over
the ﬁve day period between stages 46 and 48 (Sharma and Cline,
2010), suggesting that Sox2-expressing progenitors are relatively
quiescent at stage 48/49. We therefore collected GFP-expressing
cells at different times during normal rearing to enrich the fol-
lowing cell populations: active NPCs (aNPCs) isolated from animals
one day after electroporation at stage 46; Mature Neurons isolated
from tadpoles 5 days after electroporation at stage 46; and quies-
cent progenitors (qNPCs) isolated from the stage 49 tadpoles 1 dayafter electroporation. Our previous work also showed that rearing
stage 46 tadpoles in the dark for 24 h increased the proportion of
actively dividing progenitor cells whereas enhanced visual experi-
ence drove cells toward neuronal differentiation (Bestman et al.,
2012; Sharma and Cline, 2010). Therefore, we manipulated visual
experience to produce 2 cell groups enriched for Immature Neurons
(isolated from animals that were electroporated at stage 46 and
exposed to visual stimulation for the next 24 h) and actively dividing
NPCs (isolated from tadpoles that were electroporated at stage 46
and visually deprived for the following 24 h), called aNPCvd (Fig. 1).
We used multiple microarray analyses to identify transcripts
that were differentially expressed in cell populations enriched for
aNPCs relative to neurons or qNPCs. To do this, the expression
values of the transcripts for ﬁve replicates of each of the ﬁve
experimental conditions were normalized, outliers representing
hybridization artifacts were removed and the averages across the
probe replicates were calculated. We then made three compar-
isons of the transcript expression data from the cDNA microarrays
between the different experimental conditions described above
(Fig. 1). In one comparison, microarray data from aNPCs and
Mature Neurons were compared. The second comparison
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Fig. 2. Relationships between the multiple microarray comparisons. (A) Venn
diagram of the overlap of the transcripts with differential expression (po0.05)
between the 3 microarray comparisons. About 50% of differentially expressed
transcripts were shared between the 3 datasets. Sizes of the ovals represent the
number of transcripts showing signiﬁcant differential expression in each micro-
array comparison. The overlap represents the proportion of transcripts shared by
multiple microarray comparisons. The aNPC vs Mature Neuron set contains 1606
transcripts, 672 of which were shared with at least one other group. The aNPC vs
qNPC comparison has 932 differentially expressed transcripts, and shared 573
transcripts with other comparisons. The aNPCvd vs Immature Neuron comparison
had 702 genes with signiﬁcant differential expression, with 395 shared between
the different comparisons. In total, 124 genes were shared between all 3 gene
groups. (B) DAVID analyses reveal gene ontology traits from the microarray com-
parisons. Differentially expressed transcripts with po0.05 from the aNPC vs qNPC,
aNPC vs Immature Neuron, and aNPC vs Mature Neuron microarray comparisons
were clustered using the DAVID Functional Annotation Clustering tool. The enriched
gene clusters are shown in pie charts for each comparison. The number of transcripts
identiﬁed in each cluster is indicated in the diagram or in the legend. Transcripts in the
nucleosome and chromatin assembly pathways (black) were common to all three
microarray comparisons. The RNA recognition RNP-1 family (white) was abundant in
both the aNPCvd vs Immature Neuron and the aNPC vs Mature Neurons microarray
comparisons. These data are provided in Supplementary Table 2.
J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291 271identiﬁed transcripts that are differentially expressed in aNPCs
compared to the qNPCs. Third, aNPCvd cells were compared to
Immature Neurons. Transcripts with p-values o0.05 were con-
sidered signiﬁcant and are provided in Supplementary Table 1.
Each of the three comparisons contains an aNPC group that is
compared to either qNPCs, Immature Neurons or Mature Neurons.
Therefore, we also explore which transcripts in aNPCs are shared
across the comparisons to reveal genes that regulate continued
cell proliferation in the brain.
Relationships between the multiple microarray comparisons
To depict the differentially expressed transcripts shared between
aNPCs from the different microarray comparisons, we generated a
Venn diagram from the sets of differentially expressed transcripts
from the three datasets (Fig. 2A). The areas of the ovals in thediagram represent the relative number of differentially expressed
transcripts for each microarray comparison and the total number of
transcripts in each set is indicated. The size of the overlap between
groups represents the proportion of transcripts shared by the dif-
ferent microarray comparisons. The analysis showed that 309 dif-
ferentially expressed transcripts were shared between the aNPC vs
Mature Neuron comparison and the aNPCvd vs Immature Neuron
comparison, whereas 477 differentially expressed transcripts were
shared between the aNPC vs qNPC comparison and the aNPCvd vs
Immature Neuron comparison. Finally, 210 differentially expressed
transcripts were shared between the aNPCvd vs Immature Neuron
comparison and the aNPC vs qNPC comparison. 124 (3.8%) differ-
entially expressed transcripts were part of all three microarray
comparisons (Fig. 2A, black; Supplementary Table 1). The aNPC vs
Mature Neuron set contained the greatest number of unique tran-
scripts (934/1606; 58.2%) that were not shared between the
3 groups, compared to 43.7% (307/702) unique transcripts in the
aNPCvd vs Immature Neuron dataset and 38.6% (359/932) unique
transcripts in the aNPC vs qNPC dataset.
The differential expression analysis from the microarrays
revealed that well known markers of aNPCs, qNPCs or neurons
were signiﬁcantly expressed in the different cell groups (all genes
with signiﬁcant differential expression are listed in Supplementary
Table 1). For example, the intermediate ﬁlament protein and
marker of radial glial progenitor cells, vimentin, had signiﬁcant
differential expression in each microarray comparison. Other
genes associated with proliferating NPCs, the astrocyte speciﬁc
L-glutamate/L-aspartate transporter, slc1a3/GLAST, and the gluta-
mate–ammonia ligase, glul, were differentially expressed in the
aNPCvd vs Immature Neuron and aNPC vs qNPC comparisons. The
analysis also revealed that empty spiracles homeobox 2 (emx2), a
regulator of NPCs (Falcone et al., 2015), showed signiﬁcant differ-
ential expression in all 3 comparisons. Similarly, members of the
sox gene family (sox 2, 3, 5, 9, and 11), and the POU domain
transcription factor family (pou3f2, pou3f4 and pou4f1), transcrip-
tion factors which regulate in the maintenance of the progenitor
pool and differentiation of neurons (Tantin, 2013; Uy et al., 2015),
were differentially expressed in multiple microarray comparisons.
Genes that direct neurogenesis or are expressed in post-mitotic
neurons, such as members 1, 4 and 6 of the neurogenic differ-
entiation (NeuroD) gene family, members of the ɑ and β-tubulin
gene family, and the early B cell factors 1 and 2, for example, were
also differentially expressed across the microarray comparisons
(Supplementary Table 1). Overall, the signiﬁcant differential
expression of these and other transcripts indicates that our
methods for harvesting cells and performing the microarray ana-
lyses successfully identiﬁed genes known to be differentially
expressed in our target cell populations.
Bioinformatic analyses of the differentially expressed transcripts
Analyses of gene families and signaling pathways provide a
broader view of transcriptionally regulated cellular processes
during neurogenesis than an analysis of single transcripts. We
conducted a bioinformatic analysis using DAVID (the Database for
Annotation, Visualization and Integrated Discovery (Huang et al.,
2009)) to investigate whether gene families or pathways were
expressed in the microarray datasets. DAVID identiﬁes biological
processes, protein domains and other annotation terms in a gene
list that are signiﬁcantly enriched compared to their correspond-
ing frequencies in a background gene list. We used the transcripts
from the Affymetrix X. laevis 2.0 microarray chip as the back-
ground gene set. Using the lists of transcripts with signiﬁcant
differential expression from the microarray comparisons, Fig. 2B
shows the gene clusters that the DAVID Functional Annotation
Clustering algorithm identiﬁed as enriched relative to the
J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291272expected numbers from the microarray background. The DAVID
algorithm detected 2 gene clusters in the transcript list from the
aNPC–qNPCs comparison, 3 gene clusters in the list from the
aNPCvd–Immature Neurons comparison, and 9 gene clusters in the
list from the aNPC–Mature Neurons comparison, shown in the pie
charts in Fig. 2B. The DAVID-generated gene lists, p-values and
Benjamini false discovery rates are provided in Supplementary
Table 2.
In all three microarray comparisons, DAVID identiﬁed a cluster of
“nucleosome and chromatin assembly” genes (black, Fig. 2B), a
family known to regulate the balance between cell proliferation and
differentiation in the brain (Lilja et al., 2013; Fig. 2B and Supple-
mentary Table 2). The “RNA recognition motif, RNP-1” gene cluster
(white, Fig. 2B), which includes the proliferation regulator Musashi
(Okano et al., 2005), was identiﬁed in both the aNPC vs qNPC and
the aNPC vs Mature Neuron microarray comparisons. Two additional
gene clusters involved in RNA regulation were enriched in the aNPC
vs Mature Neuron microarray comparison: the “Sm-like ribonu-
cleoprotein, core” protein family (yellow) composed mainly of het-
erogeneous nuclear ribonucleoproteins and RNA splicing factors, and
the functionally diverse genes represented in the “nucleoside bind-
ing/tRNA aminoacylation” cluster (gray). The aNPC vs Mature Neu-
ron microarray comparison also contained two clusters associated
with mitochondrial function, the “purine nucleotide metabolic pro-
cesses/ATP synthesis coupled proton transport” cluster (magenta)
and the “cytochrome c oxidase activity” cluster (light blue), which
may reﬂect the increase in mitochondrial abundance that accom-
panies cell differentiation (Wanet et al., 2012). In addition, the
“proteasome core complex” (purple) and “actin cytoskeleton reg-
ulation” (red) clusters were also enriched among the differentially52
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Fig. 3. aNPCs share networks of differentially expressed transcripts. (A) Networks of d
positive expression values (more highly expressed in NPCs) or negative expression value
Each node of the network indicates the groups of positively (blue) or negatively (red)-ex
and thicker connections indicate that the groups share many transcripts. The size of th
genes and the number of unique genes unshared (black) and shared between groups (b
capability, gray represents enrichment in qNPCs and red indicates enrichment in neuron
the numbers of transcripts in common between the groups. (B) DAVID Functional Anno
datasets: nucleosome and chromatin assembly genes, RNA recognition motif RNP-1 fam
family and genes associated with oxygen transport.expressed genes from the aNPC vs Mature Neuron microarray
comparison. Two annotation clusters were only associated in the
aNPCvd vs Immature Neuron comparison: “iron storage” (blue) and
“oxygen transport” (tan). Genes in the “iron storage” cluster, such
ferritin light and heavy chain proteins, and in the “oxygen transport”
cluster, such as hemoglobin genes, have been associated with oxy-
gen uptake in neural tissue (Schelshorn et al., 2009). Therefore the
DAVID analysis identiﬁed gene families connected to the processes
that govern cell proliferation or neuronal function.
Fig. 2A demonstrated that 50% of all the differentially
expressed genes are shared between at least two of the microarray
comparisons. To explore this further, we were interested in whe-
ther the differentially expressed genes were similarly regulated in
each group, that is, whether they were up- or down-regulated only
in cells with high proliferative capacity or only the cells with low
proliferative capacity. In all three microarray comparisons, positive
differential expression values represent genes that are more highly
expressed under conditions that favor active cell proliferation
(aNPC or aNPCvd populations) compared to conditions of low
proliferation (qNPC, Immature Neuron, or Mature Neuron popu-
lations). We expected that genes shared across groups would be
similarly regulated (e.g. positive differential expression value in
multiple aNPC groups). To determine whether the transcripts
shared between groups were similarly regulated, we determined
the ratio of upregulated/total differentially expressed transcripts
and mapped the network of shared transcripts using the Gephi
clustering algorithm (Bastian et al., 2009; Fig. 3A). The gene net-
work generated by Gephi plots the transcripts that were upregu-
lated in aNPCs compared to the other cell groups (blue circles),
transcripts that were upregulated in the two neuron groupslow
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the qNPC group (gray) compared to aNPCs (Fig. 3A). The sizes of
the circles, or nodes, represent the relative number of differentially
expressed transcripts in each paired comparison. The blue por-
tions of the circles at each node of the network represent the
proportion of genes that are upregulated and the black portions
show the proportion of genes that are unique to the
group and unshared. The ratio of upregulated/total differentially
expressed transcripts is shown next to each node. The aNPCvd vs
Immature Neuron microarray comparison contained 389/680
transcripts with higher expression in the aNPCs (blue) and 4/25
that were more highly expressed in immature neurons (red;
Fig. 3A). Similarly, the 575/1266 transcripts in the aNPC vs Mature
Neuron comparison (blue) were upregulated in the NPCs com-
pared to 98/365 transcripts that were more highly expressed in
Mature Neurons (red). Finally, in the aNPC vs qNPC comparison,
472/656 transcripts were upregulated in the aNPCs compared to
103/284 upregulated transcripts in qNPCs (gray). This analysis also
demonstrates a high degree of overlap in the upregulated tran-
scripts across different aNPC groups, indicated as the connecting
blue bars between the blue and black nodes. The aNPCvd group
shares 252 upregulated transcripts with the aNPCs in the aNPC vs
Mature Neuron comparison and 160 upregulated transcripts with
the aNPCs of the aNPC vs qNPC group. Furthermore, the aNPC
groups shared 404 transcripts between the Mature Neurons and
qNPCs comparisons.
In contrast, Gephi identiﬁed relatively few transcripts that are
upregulated in the cell groups with low proliferative capabil-
ities (the aNPCoMature Neurons (red), aNPCoqNPC (gray) and
aNPCvdoImmature Neuron groups), and fewer transcripts were
shared between these conditions. For example, only 4 of the 25
differentially expressed transcripts were upregulated in the Imma-
ture Neurons compared to aNPCvd group, and none were shared with
the upregulated transcripts in the Mature Neuron group. Of the
98/365 upregulated transcripts in the Mature Neuron group, 60 were
similarly upregulated in the qNPC set and 52 were shared with the
aNPCvd group. Similarly, the transcripts that were upregulated in
qNPCs compared to aNPCs were roughly equally shared with cell
groups with low proliferative capability (60 transcripts in common
with upregulated transcripts in Mature Neurons) and with cell
groups with higher proliferative activity (18 with the aNPC4Mature
Neurons and 46 with the aNPCvd4Immature Neuron). Together
these analyses indicate that upregulated transcripts are a larger
proportion of the differentially expressed transcripts in aNPCs and
that more upregulated transcripts are shared between aNPCs under
different conditions, but fewer upregulated transcripts are shared
between the cell groups with lower proliferative activity.
We were interested in whether applying the DAVID Functional
Clustering tools to the list of genes that were either shared
between two or more of groups with high proliferative capability
or low proliferative capability would reveal enriched biological
pathways or processes. Of the 61 genes shared between the groups
with low proliferative capabilities, there were 44 unique genes,
and the DAVID analysis did not reveal any enriched biological
processes. The 815 genes shared between at least 2 different aNPC
groups (blue connecting lines in Fig. 3A) included 615 unique
transcripts. We reasoned that a bioinformatic analysis of these
transcripts might identify genes that were particularly important
for maintaining cell proliferation in the brain. DAVID Functional
Annotation Clustering tools identiﬁed 5 biological pathways or
processes that were abundant in this transcript group (Fig. 3B and
Supplementary Table 2). As expected, we found that some anno-
tation pathways were shared with the gene sets in Fig. 2B,
including the “RNA recognition motif, RNP-1” family, “nucleosome
and chromatin assembly” transcripts, and transcripts involved in
“oxygen transport”. Two unique gene groups were also identiﬁed:“CHROMO domain/chromatin binding” transcripts, which encode
heterochromatin proteins involved in the regulation of transcrip-
tion, and transcripts in the “chaperonin Cpn60/TCP-1” family,
known regulators of the cytoskeleton and cell cycle (Brackley and
Grantham, 2009; Fig. 3B).
Identiﬁcation of candidate human genes and disease pathways
A second analysis of the differentially expressed transcripts from
the three microarray comparisons was conducted using MetaCore,
which identiﬁes enriched canonical pathways compared to a
background gene list using a proprietary literature database of
human genes. Consequently, analysis using MetaCore is intended to
identify conserved pathways and to highlight candidate neurogenic
pathways that may be active in the human brain. Starting with
transcripts that are differentially expressed in the Xenopus micro-
arrays, we identiﬁed their human homologs and used them to
search MetaCore. MetaCore analysis of the differentially expressed
genes from both the aNPCvd vs Immature Neuron and the aNPC vs
Mature Neuron microarray comparisons identiﬁed pathways in the
immune, inﬂammatory and stress response pathways (Fig. 4, Sup-
plementary Table 3). It is noteworthy that many genes that repre-
sent immune and stress responses in MetaCore have also been
shown to associate with cell cycle processes. For example, thior-
edoxin was identiﬁed in the aNPCvd vs Immature Neuron compar-
ison. It is a key component of redox regulation, and is part of the
stress response pathway, however, thioredoxin also regulates the
G1 phase of the cell cycle by controlling cyclin D1 transcription and
the ERK/AP-1 signaling pathways (Mochizuki et al., 2009). The
genes AP-1, c-Jun, Rac2 and the C3 and C5a complement signaling
components are part of the immune response pathways identiﬁed
in the aNPC vs qNPC comparison, although each of these genes is
also involved in cell cycle control (Daveau et al., 2004; Gu et al.,
2003; Schonthaler et al., 2011; Shaulian and Karin, 2001). In addi-
tion, analysis of the differentially expressed transcripts from the
aNPC vs Mature Neuron group revealed that ubiquitin proteolytic
pathways, as well as WNT and Notch signaling pathways, which are
known regulators of cell fate and cell proliferation (Gaiano et al.,
2000), were up-regulated in aNPCs.
NanoString analysis of NPC and neuronal transcripts
We used NanoString as an independent means to compare
expression of a subset of transcripts from independent samples of
aNPCvds and Immature Neurons. We selected 95 transcripts that
included a subset of differentially-expressed transcripts identiﬁed
by the microarray analysis and other transcripts in signaling
pathways ﬂagged by the differentially-expressed candidates. Of
these, 46 transcripts shared the same expression proﬁle in both
the microarray and NanoString assays, 20 transcripts were differ-
entially expressed in the microarray assays but not in the Nano-
String, and 24 transcripts were differentially expressed in the
NanoString assay but not the microarrays. Only 5 transcripts
showed differential expression in opposite directions in the
aNPCvd and Immature Neuron comparison in the NanoString and
microarray analyses (Fig. 5, Supplementary Table 4). As further
validation of our strategy to isolate populations of cells enriched
for neurons or NPCs, elavl3, a neuron-speciﬁc RNA-binding protein,
was more highly expressed in the Immature Neurons than
aNPCvds. Furthermore, aNPCvd samples had higher expression of
NPC transcripts sox2 and musashi1, which are known to be more
highly expressed in Xenopus NPCs than neurons (Sharma and
Cline, 2010). These data provide strong, independent corrobora-
tion of the differential expression detected by microarray com-
parisons and speciﬁcally demonstrate concordance between
NanoString and microarray data for 49% of tested transcripts.
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Fig. 4. MetaCore analysis of differentially expressed transcripts in NPCs and Neu-
rons. Map Folders (left column), which identify broad functional categories, and
Canonical Pathways Maps (right column), which identify more speciﬁc candidate
interaction pathways, are listed in the order of signiﬁcance, from top to bottom of
the lists. Pathway Maps that are within Map Folders are color coded. The top 10
signiﬁcant pathways from MetaCore (po0.05 and False Discovery Rate o0.05) are
presented here. Speciﬁc components of the Pathway Maps that were identiﬁed in
the microarray comparisons are shown in Supplementary Table 3.
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neurogenesis
We selected 34 candidate genes for analysis of their roles in cell
proliferation and neuronal differentiation based on the microarray
and NanoString analyses (Table 1). We designed an in vivo imaging
strategy to test whether antisense morpholinos directed against the
candidate genes affected cell proliferation and differentiation
(Fig. 6). To conduct the morpholino knockdown screen, cells in the
tectum were electroporated with pSox2-bd::FP reporter alone, or
mixed with either a ﬂuorescently-tagged control morpholino or a
speciﬁc morpholino oligonucleotide designed to block translation of
a target gene (Bestman and Cline, 2014; Eisen and Smith, 2008). Co-
electroporation of lissamine-tagged morpholinos and pSox2-bd::FP
shows that morpholinos distribute widely through the optic tectum
and are not limited to the cells expressing the pSox2-bd::FPreporter (Bestman and Cline, 2014), as previously indicated (Falk
et al., 2007). After one day, we screened tadpoles for those with
sparsely labeled tectal lobes (approximately 20 pSox2-bd::FP-
labeled cells) for time-lapse imaging and analysis. This initial density
of labeled cells allowed accurate quantiﬁcation of cell proliferation
and differentiation within the 3D confocal stacks of the optic tectal
lobes (Bestman et al., 2012). Over the next 2 days, we collected
complete confocal z-series through 6–13 tectal lobes per group. We
analyzed the time-lapse images using Volocity software to determine
the average cell proliferation rate of FP-labeled cells over the 48-h
period, and determined the proportion of FP-labeled neurons and
NPCs at each time point for animals electroporated with morpholi-
nos. The effects of morpholino treatments were compared to results
from animals electroporated with control morpholinos.
Images collected the ﬁrst day after electroporation of stage 46
tadpoles with pSox2-bd::tGFP under control conditions revealed
that approximately half of the transfected cells are NPCs (Bestman
et al., 2012). Animals electroporated with pSox2-bd::FP alone, or
combined with control morpholinos, had comparable proliferation
rates (Tables 2–5). An example of a time-lapse series acquired from
the optic tectal lobe of an animal that was electroporated with the
control morpholino is shown in Fig. 7A1–3. The NPCs are dis-
tinguished from neurons by their radial glial morphology (Best-
man et al., 2012; Morest and Silver, 2003; Tremblay et al., 2009).
NPCs have triangular or elongated cell bodies at the ventricular
surface of the tectum and extend a slender radial process that
spans from the cell body to the endfeet on the pial surface,
examples of which are shown in Fig. 7 where the arrows point to
the distal pial endfoot of NPCs. By contrast, neurons have round or
pear-shaped somata and tend to extend a single process from
which both the axon and the dendritic arbor elaborate (the
asterisk is next to neuronal somata in Fig. 7). The quantiﬁcation of
the changing proportions of NPCs versus neurons that occurs over
the 3 day window is summarized for all control animals in Fig. 7A4
and A5 and Tables 2–4. About 10% of FP-labeled cells could not be
classiﬁed as neurons or NPCs based on morphology and are
quantiﬁed as ‘unclassiﬁed’ (Tables 2–4). These data show that
while NPC numbers decreased over the course of the experiment,
the proportion of neurons increased as the proliferating cells
generated neurons and terminally differentiated. From the 23
control animals imaged, we found that 49.572.7% of cells on the
ﬁrst day of the experiment were NPCs, dropping signiﬁcantly to
24.972.9% on day 3 (Fig. 7A4 and Tables 2–4). During this same
window, the proportion of differentiated neurons increased from
37.872.5% on day 1 to 59.273.7% on day 3 (Fig. 7A5 and
Tables 2–4).
Proliferation rates in the tectum can be affected by multiple
factors: cell survival, cell cycle length, whether the NPCs divide
symmetrically to expand the pool of proliferating cells, whether the
NPCs divide asymmetrically to maintain the progenitor pool, and
whether the NPCs terminally differentiate and thereby shrink the
progenitor pool. We found that time-lapse imaging data was critical
for the interpretation of our results, and the examples we describe
below reveal that there were mixed relationships between increases
or decreases in proliferation rates and whether there were greater or
fewer progenitor cells. Fig. 7B–D shows projections of representative
time lapse images of optic tectal lobes co-electroporated with the
pSox2-bd::FP reporter and morpholinos designed to block transla-
tion of genes from our list of candidate neurogenic regulators: glu-
tathione S-transferase pi 1 (gstp1; Fig. 7B1–3), heat shock protein 5
(hspa5; Fig. 7C1–3) and armadillo repeat containing protein 8
(armc8; Fig. 7D1–3). These three examples show the range of cell
proliferation and cell differentiation outcomes generated by the
different morpholinos we tested.
Animals treated with morpholinos directed against gstp1
represent a category of candidate genes that affected the proportion
Fig. 5. Concordance of differentially-expressed transcripts detected by NanoString and microarrays. (A) Pie chart illustrating the degree of concordance of 95 transcripts
analyzed by NanoString and microarrays. 49% of transcripts tested by NanoString share the same expression proﬁle as microarray; 25% of transcripts were detected as
differentially expressed by only NanoString analysis and 21% were detected as differentially expressed only by microarray analysis. Only 5% of the transcripts that were
differentially expressed in the NanoString analysis exhibited differential expression in opposite directions in the microarray analysis. (B) Differential expression of transcripts
analyzed by NanoString and microarrays for aNPCvd and Immature Neurons. Transcripts that are more highly expressed in aNPCvd than Immature Neurons (green), more
highly expressed in Immature Neurons (red) or not differentially expressed (white) are shown for concordant transcripts (NanoString¼Microarray) or those that were
detected as differentially expressed only by NanoString or microarray. Transcripts to the far right were differentially expressed but in opposite directions between NanoString
and microarray analyses.
Table 1
Morpholino sequences and their target genes.
MO sequence X. laevis symbol Full name Ref. seq Unigene ID
GACCCAGGTTTCGCAGACCAGACAT arl9 ADP-ribosylation factor-like 9 NM_001096919 Xl.66117
GAGGCTCCAACACGCACGCCATCTT armc8 Armadillo repeat containing 8 NM_001096774 Xl.19526
CGTTGTCGAATAAAGTGAGAGCCAT chn1 Chimerin (chimaerin) 1 NP_001080335 Xl.56738
GCCAAATTGAATTTCAATGCAATCG cpeb1-a Cytoplasmic polyadenylation element binding protein 1 NM_001090603 Xl.984
AGGAGCCCCGGAGTCCGCATCATCC ctdnep1-a CTD nuclear envelope phosphatase 1 (dullard) NM_001096787 Xl.76057
GCAGTGCAACATGGTGCTCAGCCCT dio3 Deiodinase, iodothyronine, type 3 NM_001087863 Xl.862
AAAGAAGCACAAACACCACAGCCAT efna3 Ephrin-A3 NM_001087027 Xl.47030
AAGTAGACCGGCATTGCGGCAGATA eif3a Eukaryotic translation initiation factor 3 subunit A NM_001091816 Xl.3189
GCCACAAAGTGATAGCACTATCCAT elk4 ELK4, ETS-domain protein (SRF accessory protein 1) NM_001085854 Xl.782
GTAGCAGCAGCACATTTAGTTCCAT ephb1 EPH receptor B1 NM_001090601 Xl.1028
CAGGAGCCATTTTCTGTAGCACAAA epx Eosinophil peroxidase NM_001088379 Xl.424
CCACAGACAGCAGTTCCTGATTCAT fbxw7 F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase NM_001095717 Xl.32837
GAGTTGTGATGCTCCCTGCCGCCAT fgf2 Fibroblast growth factor 2 (basic) NM_001099871 Xl.76214
AGCTCCTCCATGTTGCGTCCGCACA fmr1-a Fragile X mental retardation 1 NM_001085687 Xl.3332
GCACTTCCACCGTCATGTCCTCCAT fxr1-a Fragile X mental retardation, autosomal homolog 1 NM_001088317 Xl.331
TCTTCTTTGGTCTTTCCAAAATGCC glis2-a GLIS family zinc ﬁnger 2 NM_001088623 Xl.30097
AATAGGTGAGGACGTAGCCAGGCAT gstp1 Glutathione S-transferase pi 1 NM_001088783 Xl.54920
ACTCAGCCAATTTCTTTTCCATAGC hat1 Histone acetyltransferase 1 NM_001094404 Xl.43663
GGGCACTAGACACAAACAAGTGCAC hdac6 Histone deacetylase 6 NM_001087017 Xl.8310
AGGCAAACAGCTTCATGGTCACCAT hspa5 Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) NM_001086595 Xl.21814
GCGCAGGCTCATCCTAGTTTCCTTT lsm6 LSM6 homolog, U6 small nuclear RNA associated NM_001093849 Xl.48776
CGCTCGGCGCAGCGGCCATTTTCTC mecp2 Methyl CpG binding protein 2 (Rett syndrome) NM_001088385 Xl.439
ACGTGTTTGATGCTCATTGCCGCTC mkrn2 Makorin ring ﬁnger protein 2 NM_001096637 Xl.84320
ATTGTGCTCCTCATAATGATCCATC actn1/MGC81191 Uncharacterized protein MGC81191; homolog to ACTN1, actinin, alpha 1 NM_001091370
AGACTAAAACTCCCACCCTACCCAT mmp9 Matrix metallopeptidase 9 (92 kDa gelatinase/type IV collagenase) NM_001086503 Xl.526
ATCTGTGAATCCGTTTCATCCATTC mocs3 Molybdenum cofactor synthesis 3 NM_001095850 Xl.52919
TCTTTGTGGTAGCCGCGTTGCCCAT prkaca Protein kinase, cAMP-dependent, catalytic, alpha NM_001099869 Xl.83942
CGCTTCCACTGTCTCTATCCGCCAT pura Purine-rich element binding protein A NM_001093440 Xl.3084
CATGGGACATCTTCAGCATAATACA r3hdm2 R3H domain containing 2 NM_001095964 Xl.15158
CATCAGACATTACAGCATCTGCCAT rbfox2-b RNA binding protein, fox-1 homolog 2 NM_001091634 Xl.14636
AGCCCGGTTTTCCTGCTTGCTCCAT slc12a2 Solute carrier family 12 (Na+/K+/Cl- transporters), member 2 (NKCC1) NM_001122599 Xl.84328
TCGGAGGTCTGTTTTGAGGGAACAT tle1 Transducin-like enhancer of split 1 (E(sp1) homolog) NM_001096979 Xl.57178
AGTGGTTGGATTCCGTGTCCATATC vangl1 VANGL planar cell polarity protein 1 NM_001096375 Xl.2505
TCCAGTTGCGGAAGTGTCTGTGCAT wnt7b Wingless-type MMTV integration site family, member 7B NM_001090733 Xl.229
GCGAAATTCAATTTGAATCCAATGG Control – – –
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J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291276of NPCs within 24 h after electroporation. Fig. 7B1–3 shows a time
lapse series from the right optic tectal lobe of a gstp1-MO treated
animal with a high number of differentiated neurons on day 1
(asterisk in Figs. 7B1–3 indicates a neuron with a mature dendritic
arbor that is visible at each time point). Figs. 7B4 and B5 show theMeasure cell 
proliferation in tectum 
over 48 hours
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Fig. 6. In vivo time-lapse imaging protocol. We electroporated optic tecta of stage
46 tadpoles with pSox2-bd::tGFP and control morpholinos (MO) or MOs targeted
against genes of interest. After 24 h, all tGFP-labeled cells in each tectal lobe were
imaged at daily intervals over 3 days.Cell proliferation over 2 days and the pro-
portions of labeled NPCs and neurons were determined for each timepoint.
control 
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Fig. 7. Morpholinos against candidate neurogenic genes alter cell proliferation and differ
after co-electroporation with pSox2-bd::tGFP and control morpholinos (A1–A3), or mo
containing 8 (armc8; C1–C3), or heat shock protein 5 (hspa5; D1–D3), GFP-labeled cells a
of example neural progenitor cells and asterisks indicate neurons. Under control conditi
tectal lobes with targeted gene knockdown show decreases (gstp1 and hspa5) and incre
neurons (gstp1 and armc8) on the third day of imaging. A4–D4, A5–D5 Summary grap
pholino-treated (B–D) animals that are NPCs (A4–D4) or neurons (A5–D5). Each line re
signiﬁcant difference from the mean control values (Mann–Whitney U test, po0.05) an
between day 1 and day 3 levels (Wilcoxon Signed Rank test, po0.05). Summary graphs f
shown in Tables 2–5.results from the 7 animals that we imaged, indicating that by the
time the ﬁrst image was acquired, electroporating optic tecta trea-
ted with the gstp1 morpholino had reduced the NPC population to
12.574.2% of all cells in the optic tectum (p¼0.001) or 28.879.9%
of control levels. gstp1 MO treatment concurrently increased the
neurons to 72.274.4% of the cell population (po0.01) or
186.3711.1% of control levels (Fig. 7B4–5 and Table 2). By day 3, the
NPCs made up only 5.674.9% of the total cell population, just
26.278.5% of control levels (p¼0.005), and at 85.472.3% of the cell
population, neurons were 151.274.1% of control levels (p¼0.001).
Compared to control conditions, treatment with gstp1-MO also
inhibited the rate at which NPCs differentiated, yielding fewer cells by
day 3 of the time lapse series (Fig. 7B3 and Table 4). Consequently, we
did not detect changes in the proportion of the different cell types
over the 3 day experiment compared to controls (Table 3).
Treatment with morpholinos against hspa5 also signiﬁcantly
limited proliferation in the tectum (Fig. 7C, Table 5), but our resultsY 3
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0
entiation. A1–D3 Projections of confocal stacks of the right tectal lobe imaged 1 day
rpholinos against glutathione S-transferase pi 1 (gstp1; B1–B3), armadillo repeat
re relatively sparse on day 1 (A1, B1, C1, D1). Arrows point to the distal pial endfoot
ons, the number of NPCs decreases over the subsequent two days (A2 and A3). The
ases (armc8) in cell proliferation, as well as higher proportions of NPCs (hspa5) or
hs of changes in the proportion of cells in the tectum of the control (A) and mor-
presents data from a separate animal. An asterisk over day 1 or day 3 indicates a
d an asterisk over the center bracket indicates that there was a signiﬁcant change
or all control and morpholino results are provided in Supplementary Fig. 1. Data are
J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291 277suggest that hspa5 and gstp1 act through different mechanisms. MOs
against hspa5 did not limit the numbers of progenitors or neurons
on the ﬁrst day of imaging (107.0718.7% and 113.8716.2% of
control levels, respectively, p-values 40.6; Fig. 7C and Table 2). By
the 3rd day of the time lapse imaging experiment, 50.676.7% of the
GFPþ cells in tecta electroporated with the hspa5 morpholino
remained NPCs (arrow Fig. 7 C1–3), 234.3730.9% of control values
(p¼0.002). The number of neurons (asterisk, Fig. 7C1–3) from the
hspa5 MO treated animals was only 65.377.2% of control values, a
signiﬁcant reduction to just 36.974.1% of the total cell population
(p¼0.02). The pairwise comparisons failed to reveal the expected
decrease in the NPC population and increase in differentiated neu-
rons between day 1 and day 3 seen in controls (Wilcoxon Signed
Rank test, p-values¼0.16; Fig. 7C4 and C5 and Table 4). This resulted
in an overall decrease in cell proliferation for the hspa5 morphants
(Fig. 8A, and Tables 3 and 5). These data suggest that morpholinos
against hspa5 prolonged the cell cycle and limited the differentiation
of NPCs into neurons. In contrast, morpholinos against gstp1 also406080100
% Neurons on % Change in Cell # over 3 days
0 50 100 150 200
conMO
prkaca
fmr1a
fxr1
hspa5
mmp9
gstp1
cpeb1-a
mkrn2
wnt7b
efna3
hdac6
epx
tle1
slc12a2
vangl1
dio3
elk4
r3hdm2
eif3a
mecp2
rbfox2-b
hat1
pura
fbxw7
glis2
fgf2
actn1
arl9
lsm6
chn1
ctdnep1
ephB1
mocs3
amrc8
Fig. 8. Morpholinos against candidate neurogenic genes generate a range of neurogenes
labeled cells generated over time (A), the proportion of the cells that were neurons (B) or
are arranged by the magnitude of the change in cell number over 3 days. The asterisks in
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graphs indicate the mean control morpholino (conMO) values for the proportion of neudecreased neurogenesis but did so by promoting progenitors to exit
the cell cycle, depleting the progenitor pool and increasing
differentiation.
A different proliferation phenotype was detected in animals
electroporated with the morpholino directed against armc8. Like the
hspa5morphants, the initial proportions of NPCs (arrow, Fig. 7D1–3)
and neurons (asterisk, Fig. 7D1–3) were not different on the ﬁrst day
of the experiment (99.1711.9% and 82.8725% of control values,
respectively, p-values 40.2; Fig. 7D2 and Table 2). Comparing
Fig. 7D1 and D3 reveals that, compared to control conditions, the
armc8 morpholino increased cell proliferation by generating a
higher proportion of differentiated neurons over the 48 h period.
Pairwise comparisons of the armc8 morphants revealed signiﬁcant
increases in the proportions of neurons and decreases in NPC
numbers between day 1 and day 3 (p-values o0.02; Table 4),
similar to control MO results. The data from all armc8 morpholino
treated animals (n¼8) are summarized in Fig. 7D4 and D5, which
show that the magnitude of the changes in cell proportions020
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J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291278surpassed those found in the control animals. The animals treated
with armc8 had signiﬁcantly higher numbers of neurons on day
3 compared to control values (74.774.6% neurons on day 3;
p¼0.0037), which reduced the remaining proliferating cells to just
10.072.4% of the total cell population, signiﬁcantly less than the
control values (po0.0001; Table 2 and Fig. 7D4 and D5). These data
indicate that MOs against armc8 may act to shorten the cell cycle
time and increase rates at which NPCs leave the progenitor pool and
differentiate. Together these examples illustrate the value of our
time-lapse imaging approach to test how genes affect cell pro-
liferation and differentiation in the optic tectum based on direct
observation of NPCs and their progeny. Similar graphs of the chan-
ging proportions cell types for all control animals and each set of the
34 experimental morpholino groups are provided in Supplementary
Figs. 1–3.
Morpholinos generate a range of cell proliferation and neurogenesis
phenotypes
The time lapse experiments and quantiﬁcation shown in Fig. 7
give three examples that capture the range of cell proliferation and
differentiation phenotypes that we measured from animals treated
with the morpholinos designed against the 34 candidate genes. In
Fig. 8A, the results of all experiments are summarized and the data
are organized in the order of lowest proliferation (bottom of the
graph) to highest levels of proliferation (top of the graph) with the
control value as the bottom-most bar and red line in the graph
(Fig. 8A). We found that 12 of the 34 morpholinos tested increased
the proliferation rate, yielding higher numbers of GFP-positive
cells on day 3 compared to control values. These are: actinin1
homolog (actn1 homolog, MGC81191); armc8; ADP-ribosylation
factor-like 9 (arl9); chimerin 1 (chn1); CTD nuclear envelope
phosphatase 1 (ctdnep1a/Dullard); ETS-domain protein (elk4); EPH
receptor B1 (ephb1); ﬁbroblast growth factor 2 (fgf2); GLIS family
zinc ﬁnger 2 (glis2); histone deacetyltransferase 1 (hat1); LSM6
homolog - U6 small nuclear RNA associated (lsm6) and molybde-
num cofactor synthesis 3 (mocs3). Treatment with these mor-
pholinos produced a wide range of cell proliferation responses by
the cells in the optic tectum. The smallest signiﬁcant increase in
cell number over 48 h was detected after electroporation of the
elk4 MO (37.778.0% increase, p¼0.05), or an increase to
181.7738.7% of control values. The largest increase occurred with
the armc8 MO, which resulted in a 179.1749.8% increase in cell
numbers (p¼0.003), or 763.97212.7% of control values (Figs. 7D,
8A and Table 5). Seven of the 34 morpholinos tested decreased
the proliferation rate compared to controls: cytoplasmic poly-
adenylation element binding protein 1a (cpeb1-a); gstp1; fragile X
mental retardation 1a (fmr1a); fragile X mental retardation auto-
somal homolog 1 (fxr1); hspa5; matrix metallopeptidase 9 (mmp9)
and cAMP-dependent protein kinase catalytic subunit alpha
(prkaca). The prkaca MO inhibited cell proliferation most severely,
decreasing the proliferation rate to 10.776.4% over 48 h, or
51.5730.7% of control levels (p¼0.003; Fig. 8A and Table 5). In
contrast, the cpeb1 morpholino decreased the cell proliferation
rate to 29.5718.7% of the mean control levels, or an average
increase in cell number of 6.273.8% over 48 h, which was the
most modest decrease that was signiﬁcantly different from control
levels (p¼0.03).
We also determined whether the morpholinos altered the fate
of the labeled cells by comparing the proportion of NPCs and
differentiated neurons that were generated by day 3 of the time
lapse. Animals electroporated with pSox2-bd::FP alone or with
control morpholinos had comparable proportions of neurons,
NPCs and unclassiﬁed cells (Table 3). Figs. 8B and C summarize the
proportion of neurons and NPCs seen 3 days after electroporating
morpholinos into the tectum. Data are arranged such thatmorpholinos that produced in highest proportions of differ-
entiated neurons are at the top and those that produced the
lowest levels at the bottom of the graph. Control values are given
in the bars at the bottom of the graph and with the red lines. 20
out of 34 morpholinos produced in a signiﬁcant difference in the
distributions of cell types compared to control animals (Pearson
Chi-square value o0.05, names listed in red in Fig. 8B–C; data
given in Table 3). We followed up these Pearson Chi-square ana-
lysis with Mann–Whitney U tests to determine which cell types
differed in response to the morpholino treatments. Compared to
the proportions of cell types found in control conditions, the
proportions of NPCs were signiﬁcantly different with the following
5 morpholino treatments: armc8, chn1, gstp1, hdac6 and hspa5
(marked with asterisks, Fig. 8C; Table 3). Morpholinos against
armc8, gstp1, and hspa5 also altered the expected proportions of
labeled neurons compared to controls. A summary of the differ-
ential expression analysis and in vivo imaging analysis is shown in
Table 6.
Candidate gene analysis identiﬁes subsets of mechanisms that reg-
ulate neurogenesis
The in vivo imaging data (Figs. 7 and 8, Supplementary Fig. 1–3,
and Tables 2–6) indicate that the different morpholinos generate a
range of phenotypes with respect to cell proliferation and differ-
entiation. To determine whether the different neurogenesis phe-
notypes, for instance changes in the numbers of NPCs and neu-
rons, show separate or nested realtionships, we generated a Venn
diagram of the subsets of morpholino-induced phenotypes seen
with the set of 34 genes (Fig. 9). Three genes targeted with the
morpholino experiments altered numbers of neurons generated by
day 3 (light blue, Fig. 9). All three of these genes were also among
the set of 5 morpholinos where the proportions of NPCs were
altered as well (purple set, Fig. 9). We found a reciprocal relationship
between numbers of neurons and NPCs; when neuron numbers were
signiﬁcantly decreased (i.e., hspa5; Figs. 7 and 8), NPCs were sig-
niﬁcantly decreased; when neuronal numbers were increased (i.e.,
gstp1 and armc8; Figs. 7 and 8), NPCs were signiﬁcantly decreased
(Table 4 and Fig. 8) compared to control levels.
When morpholinos alter proliferation rates, they were also
likely to change the ratio of cell types imaged on day 3. Twenty
genes targeted with morpholinos produced a signiﬁcant change in
the proportions of cell types generated compared to controls (dark
blue set in Fig. 9, the genes indicated with red font in Fig. 8, and
Table 5). All but two of the morpholinos that resulted in signiﬁcant
changes to the proportions of cell types on day 3 also altered the
cell proliferation rates (yellow set). Of the 19 genes that altered
proliferation rates (yellow set, Fig. 9), 15 were among those that
showed signiﬁcant changes to the proportions of cell types gen-
erated compared to controls (the overlap indicated with green,
Fig. 9). We found that only morpholinos against hdac6 (peach
color, Fig. 9) altered the proportion of a cell type (a signiﬁcant
decrease in the number of NPCs) without altering the level of cell
proliferation in the tectum. This analysis shows the nested rela-
tionship of the neurogenesis phenotypes and suggests mechanistic
pathways governing neurogenesis.Discussion
Summary of major observations
Many studies designed to identify genes regulating neurogenesis
are conducted under conditions in which neural stem or progenitor
cells are removed from their native environment in the intact ani-
mal. Such an experimental design precludes the opportunity to
Table 2
Average proportions of cell types on day 1 with comparisons to control values.
Radial glial progenitors Neurons Unclassiﬁed
Morpholino (N) %7SEM Mann–Whitney
unpaired p-
values
% Of control
levels7SEM
%7SEM Mann–Whitney
unpaired p-
values
% Of control
levels7SEM
%7SEM Mann–Whitney
unpaired p-
values
% Of control
levels7SEM
conMO Group 1
(11)
43.173.4 – 99.978 39.873.4 – 10078.6 1774.1 – 100724
arl9 (8) 51.773.4 0.5889 93.576.2 4174.4 0.3347 114712.4 7.173.4 0.7803 82.5739.9
armc8 (8) 54.876.6 0.6158 99.1711.9 29.879 0.2468 82.8725 15.374.5 0.2407 177752.9
chn1 (7) 59.375.6 0.5538 107.2710.1 19.972.2 0.0052 55.376.1 20.774.6 0.0218 239.5753.9
ctdnep1-a (8) 70.175.5 0.0038 126.679.9 22.576.5 0.0474 62.7718.1 7.372.3 0.1157 84.5727.6
eif3a (8) 65.878.4 0.1322 119715.2 20.576.1 0.0252 57.1717.1 13.573.4 0.2763 156.2740.2
fbxw7 (8) 54.772.2 0.9385 98.873.9 30.672.6 0.5627 84.977.2 14.772.9 0.1519 169.9734
fgf2 (9) 50.474.4 0.4136 91.277.9 37.174.4 1 103.1712.3 12.372.5 0.2106 143.1729.3
glis2 (8) 59.576.8 0.6159 107.6712.3 30.473.9 0.5883 84.5710.9 1073.4 0.7544 115.7740
hat1 (8) 52.773.7 0.7574 95.276.6 27.874.6 0.4177 77.3712.9 19.472.8 0.0247 224.7732.5
lsm6 (8) 58.573.6 0.9692 105.876.6 25.272.9 0.0825 70.178.2 16.171.7 0.0223 186.8720.2
mecp2 (8) 38.874.5 0.015 70.178.1 48.373.8 0.0371 134.3710.5 12.872.2 0.1752 148.1725.6
MGC81190/actn1
(9)
59.773.5 0.3552 107.976.5 26.972.7 0.145 74.977.7 13.272.4 0.1524 153.3728.2
mkrn2 (8) 50.277.3 0.3742 90.7713.2 40.276.1 0.4174 111.8716.9 9.573.5 0.9377 109.7740.9
mocs3 (9) 6276.6 0.5218 112.1712 27.174.8 0.3369 75.2713.4 10.873.5 0.6121 125.3741.1
pura (8) 5777.4 1 103.1713.4 36.576.3 0.7871 101.5717.7 6.372.7 0.55 73.5731.5
r3hdm2 (8) 6275.1 0.2027 11279.2 28.174.8 0.2797 78.2713.4 9.871.9 0.5599 113.4722.4
rbfox2b (9) 42.675.2 0.0593 76.979.5 47.775.7 0.081 132.6715.9 9.671.8 0.5914 111.3721.3
slc12a2 (9) 54.876.7 0.6958 99712.2 27.874.6 0.3026 77.5713 17.274.2 0.0998 199.5748.5
tle1 (8) 4673.6 0.0825 83.176.5 43.973.1 0.1135 121.978.8 1070.9 0.4385 116.1710.6
vangl1 (7) 51.773.9 0.4465 93.577.1 3274.3 0.7036 89712.1 16.172.5 0.0745 186.6729.2
conMO Group 2
(12)
55.373.3 – 10076.1 35.973.7 – 100710.4 8.672.6 – 99.9731.1
cpeb1-a (10) 32.274.4 0.0317 74.7710.3 54.773.5 0.0112 137.578.9 1372.2 1 76.3713.4
dio3 (9) 42.678.2 0.9092 98.8719.1 42.576.7 0.8197 106.9716.8 14.772.7 0.7034 86.7716.3
efna3 (6) 29.777.7 0.1445 68.8718 57.277.4 0.0786 143.7718.6 1374.6 0.8798 76.7727.4
elk4 (11) 27.974.8 0.0126 64.8711.3 47.474.8 0.2638 119.1712 24.573.9 0.0817 144.4723.1
ephb1 (5) 56.3711.5 0.3349 130.4726.8 1676.3 0.0127 40.2716 27.678.9 0.2811 162.3752.6
epx (14) 36.873.5 0.1887 85.378.2 40.474.5 0.8911 101.5711.4 22.773.4 0.171 133.4720.5
fmr1-a (8) 50.5711.5 0.9341 117726.6 25.877.1 0.1264 65718 23.577.4 0.6494 138.4743.8
fxr1-a (10) 3677.9 0.0778 83.5718.3 39.878.2 0.9438 100.1720.6 2477.6 0.7245 141.4744.7
gstp1 (7) 12.474.2 0.0011 28.879.8 74.174.4 0.0006 186.3711 13.373.6 0.4685 78.5721.6
hdac6 (6) 15.776.1 0.0103 36.5714.2 61.776.8 0.0307 155.1717.2 22.477.4 0.2079 132743.8
hspa5 (7) 46.278 0.8207 107718.7 45.376.4 0.6505 113.8716.1 8.572.7 0.2364 49.8715.9
mmp9 (6) 25.377.9 0.1188 58.5718.4 56.677.2 0.0873 142.3718.2 1874 0.546 106723.5
prkaca (6) 2278.3 0.0267 51719.4 61.278.7 0.0347 153.9721.8 16.773.2 0.6507 98.1718.8
Wnt7b (8) 46.874.6 0.5913 108.6710.8 37.675.6 0.4818 94.6714.1 15.473.2 0.7097 90.5719.2
noMO Control
(13)
35.374.4 0.2022 81.8710.3 45.673.5 0.4512 114.778.8 1974.3 0.9077 111.6725.7
conMO Combined
(23)
49.572.7 – – 37.872.5 – – 12.6772.52 – –
Each control morpholino group (conMO group 1 and group 2) is compared to the experimental MO data acquired over the same period (experimental results grouped below
each control group). All pSox2-bd::FP labeled cells in a tectal lobe were categorized as neurons, radial glial progenitors or unclassiﬁable/undifferentiated cells and the mean
percent of each cell type and standard error of the mean (SEM) are given. The % of control values7SEM is calculated by dividing the cell percentage of the experimental
group by the control value. Mann–Whitney Unpaired tests were conducted for differences in the percent of each cell type compared to control values and the p-values are
given. Signiﬁcant differences from control values are in bold. N¼number of electroporated tecta examined. The "conMO Combined" data averages all control MO values and
is displayed in Figs. 7 and 8; it is not used for statistical comparisons.
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events in the intact system. Our previous studies in the tadpole
visual system demonstrated that visual deprivation increases cell
proliferation within the optic tectum, while stimulation of the
developing visual circuits in the optic tectum drives newly generated
cells to differentiate into neurons (Bestman et al., 2012; Sharma and
Cline, 2010). Here we used in vivo manipulations of neural circuit
activity to bias populations of Sox2-expressing GFP-labeled NPCs
toward different fates (neurons or NPCs), followed by and differ-
ential expression analysis of transcripts from the enriched cell
populations in an effort to identify a broad range of neurogenic
transcripts and signaling pathways. Bioinformatic analysis of the
microarray data indicates that experimental conditions designed to
enrich for NPC or neuron populations consistently identiﬁed sig-
naling pathways related to cell cycle regulation and celldifferentiation. In vivo time-lapse imaging of neurogenesis in the
optic tectum demonstrated that morpholinos against 24 of 34 can-
didates regulated cell proliferation, cell differentiation or both in the
intact animal (Fig. 10). Our high success rate at identifying candi-
dates that when knocked down altered neurogenesis, validates the
logic of the screen. The candidates that we tested by morpholino
treatment appear to fall within diverse signaling pathways, sug-
gesting that additional genes within these signaling pathways would
be worth testing for in vivo neurogenic effects.
Logic of the microarray screen and validation of the logic
We were interested in using gene expression proﬁling to
identify candidate transcripts that might regulate cell proliferation
and neurogenesis in vivo. To do this we took advantage of the
Table 3
Proportions of cell types generated by day 3 with comparisons to control values.
Proportion of cell types, day 3 % of control levels7SEM Pearson's Chi-
square
Mann–Whitney Unpaired p-values
Morpholino % Progenitors % Neurons % Unclassiﬁed Progenitors Neurons Unclassiﬁed Progenitors Neurons Unclassiﬁed
conMO Group 1 21.5710.8 56.575.5 21.974.4 100715.1 10079.8 100720.3 – – – –
arl9 18.879.8 62.274.5 18.873.1 67.4712.4 100.877.4 182.8730.5 0.003 0.2311 0.589 0.059
armc8 10.176.8 74.774.5 15.172.9 36.278.6 12177.3 146.8728.4 o0.0001 0.0485 0.037 0.203
chn1 8.274.8 67.473.3 24.272.9 29.676.6 109.275.4 235728.4 o0.0001 0.0222 0.22 0.008
ctdnep1-a 21.6711.9 64.673.9 13.772.5 77.2715.1 104.776.3 132.8724.5 0.081 0.2969 0.487 0.216
eif3a 12.576.9 71.873.1 15.572 44.978.8 116.475 150.9720.1 0.001 0.0583 0.083 0.105
fbxw7 22.278.3 58.273.8 19.671.7 79.4710.6 94.276.1 190716.5 0.012 0.2463 0.908 0.015
fgf2 23.9714.5 62.375.1 13.671.6 85.6717.3 10178.2 132.5716.2 0.046 0.569 0.57 0.145
glis2 13.778.2 75.873.1 10.472.7 49710.4 122.875.1 101.2726.7 o0.0001 0.0693 0.083 0.816
hat1 25.276.3 5671.9 18.770.9 90.278 90.873.1 181.478.8 0.024 0.3341 0.7 0.019
lsm6 18.676.5 62.473.4 18.972.2 66.578.3 101.175.6 183.6721.8 0.003 0.2023 0.512 0.049
MGC81191/actn1 17.379.2 68.173.4 14.573 62711.6 110.475.5 140.4729.6 0.024 0.1444 0.136 0.455
mecp2 17.279 69.773.4 12.972.7 61.9710.7 112.975.6 125.6726.6 0.017 0.1319 0.154 0.354
mkrn2 20.5711.2 71.174.3 8.472.2 73.3714.1 115.177.1 81.4721.5 0.397 0.1641 0.097 0.938
mocs3 17.8711.8 7373.5 9.171.4 63.8714.1 118.375.7 88.2714.2 0.016 0.1346 0.114 0.877
pura 23.178.7 68.173.2 8.772.2 82.7711 110.475.2 84.3721.9 0.766 0.3536 0.19 0.907
r3hdm2 27.3714.3 55.774.3 16.872 97.9718.1 90.277 163.7719.7 0.067 0.9692 0.847 0.07
rbfox2-b 22.7710.4 65.974.7 11.273.1 81.3712.4 106.877.7 109.4730.1 0.317 0.213 0.5 0.695
slc12a2 22.8713.6 62.975.1 14.272.3 81.7716.3 101.978.4 137.7723.2 0.118 0.4335 0.335 0.231
tle1 20.577.6 70.872.9 8.671.7 73.579.6 114.674.8 83.9717.4 0.073 0.2162 0.143 1
vangl1 16.378.3 73.973.5 9.771 58.3711.2 119.875.8 94710.2 0.016 0.1624 0.099 0.582
conMO Group 2 27.9716.1 61.774.9 10.372.7 100716.6 99.978 100726.5 – – – –
cpeb1-a 17.5713.9 70.774.9 11.772.1 80.9720.3 125.178.7 53.779.7 0.259 0.3787 0.149 0.17
dio3 28.1722 51.875.7 2073 130.2734 91.7710.1 91.4714 0.149 0.5433 0.703 0.909
efna3 2779.5 57.373.9 15.671.6 125.1718 101.477 71.377.6 0.551 0.4211 0.92 0.651
elk4 14.976.6 60.774.7 24.273.7 69.179.3 107.578.4 110.9716.9 0.017 0.1075 0.511 0.108
ephb1 26710.1 50.975 2374 120.6721.1 9078.8 105.2718.2 0.044 0.5711 0.571 0.91
epx 18.5711 5873.5 23.373.2 86713.6 102.776.2 106.7714.9 0.083 0.4595 0.722 0.805
fmr1-a 20.3715.6 60.676.9 1974.7 94.1725.6 107.2712.2 86.9721.4 0.582 0.8365 0.71 0.649
fxr1-a 21.4719.3 57.976.4 20.576.3 99.3728.3 102.6711.3 93.9729.1 0.041 0.7512 0.916 0.596
gstp1 5.674.9 85.472.3 8.871.5 26.278.5 151.274.1 40.377.3 o0.0001 0.0057 0.001 0.024
hdac6 8.6712 71.579.1 19.776.2 40.2722.6 126.5716.2 90.4728.7 0.001 0.0389 0.107 0.725
hspa5 50.6717.6 36.974.1 12.574.5 234.3730.9 65.277.2 57.1720.8 o0.0001 0.0021 0.018 0.204
mmp9 10.6713.5 73.278.2 16.175.4 49.1725.5 129.5714.6 73.9725.1 0.023 0.0559 0.097 0.451
prkaca 11.2712.7 73.177 15.673.3 52.1724 129.3712.3 71.3715.3 0.062 0.1074 0.097 0.514
wnt7b 34.8722.4 53.676 11.575.3 161.3736.7 94.8710.7 52.6724.4 0.071 0.1731 0.836 0.083
No morpholino 14.1712.4 62.973.8 22.874.2 65.6715.9 111.376.7 104.5719.4 0.359 0.1245 0.401 0.794
conMO Combined 21.5710.8 59.273.7 15.972.8 100715.1 10079.8 100720.3 – – – –
Each control morpholino group (conMO group 1 and group 2) is compared to the experimental MO data acquired over the same period (experimental results grouped below
each control group). All pSox2-bd::FP labeled cells in a tectal lobe were categorized as neurons, radial glial progenitors or unclassiﬁable/undifferentiated cells and the mean
percent of each cell type and standard error of the mean (SEM) are given. The % of control values7SEM is calculated by dividing the cell percentage of the experimental
group by the control value. Pearson Chi-square values for differences in the distributions of cell populations between each control morpholino group (conMO group1 or
conMO group 2) and experimental morpholino groups are given. Mann–Whitney Unpaired tests were conducted for differences in the percent of each cell type to the control
values and the p-values are given. Signiﬁcant differences from control values are in bold. The "conMO Combined" value averages all control MO values and is displayed in
Figs. 7 and 8; it is not used for statistical comparisons.
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harvested tectal cell populations enriched for NPCs or differ-
entiated neurons. Optic tectal cells were collected from tadpoles at
different stages of development and with different visual experi-
ence, and RNA was isolated only from cells expressing our pSox2-
bd::FP cell-speciﬁc reporter, which is expressed in Sox2-expres-
sing NPCs and their lineages. By comparing the cell groups in the
manner described at the bottom of Fig. 1, we made 3 independent
comparisons, each designed to reveal transcripts involved in cell
proliferation and neurogenesis pathways. NanoString analysis of
tectal cell populations enriched for aNPCs and Immature Neurons
demonstrated approximately 50% concordance between the Nano-
String and microarray data.
A critical aspect to our experimental strategy was the NPC-speciﬁc
reporter we used to isolate cells for differential expression analysis
and to image NPCs in the optic tectum. It is widely recognized that
neural stem cells have heterogeneous responses to extrinsic signals
which affects their proliferative capacity, cell differentiation and
lineages (Alvarez-Buylla et al., 2008; Bonaguidi et al., 2011, 2012;Carney et al., 2012; Encinas et al., 2006; Giachino and Taylor, 2009;
Lugert et al., 2010; Maisel et al., 2007; Park et al., 2012; Song et al.,
2012; Vergano-Vera et al., 2009). By harvesting and imaging only cells
labeled by pSox2bd::GFP expression, we limited the heterogeneity of
the cell populations that we analyzed. A second critical aspect of our
strategy was that intact animals were reared under conditions known
to affect NPC proliferation and fate to enrich for speciﬁc cell popula-
tions. A third element of our experimental design was by conducting
multiple microarray comparisons in parallel, in addition to perform-
ing the NanoString analysis, identiﬁed transcripts that are differen-
tially expressed in actively dividing NPCs compared to neurons.
One gene proﬁling comparison between aNPCvd and Immature
Neurons was based on our observation that visual deprivation
increased NPC proliferation and expanded the progenitor pool,
whereas visual experience increased neuronal differentiation
(Bestman et al., 2012; Sharma and Cline, 2010). Studies in other
systems have also suggested that early brain activity regulates
stem cell fate and neuronal differentiation (LoTurco et al., 1995;
Nacher and McEwen, 2006; Reynolds et al., 2008). We anticipated
Table 4
Pairwise comparisons of changing percentages of cell types between day 1 and day 3.
% Neural progenitor cells % Neurons % Unclassiﬁed
Morpholino Day 1 Day 3 Wilcoxon
p-value
Day 1 Day 3 Wilcoxon
p-value
Day 1 Day 3 Wilcoxon
p-value
conMO group 1 55.473.4 27.974.7 0.0005 3673.8 61.775 0.0024 8.772.7 10.372.7 0.5693
arl9 51.873.5 18.873.5 0.0078 4174.5 62.374.6 0.0078 7.173.5 18.973.2 0.0078
armc8 54.976.6 10.172.4 0.0078 29.879 74.774.5 0.0078 15.374.6 15.272.9 0.9453
chn1 59.475.6 8.371.9 0.0156 19.972.2 67.573.3 0.0156 20.774.7 24.372.9 0.4688
ctdnep1-a 70.175.5 21.674.2 0.0078 22.676.5 64.773.9 0.0078 7.372.4 13.772.5 0.1953
fbxw7 54.772.2 22.273 0.0078 30.672.6 58.273.8 0.0078 14.772.9 19.671.7 0.1094
fgf2 50.574.4 23.974.8 0.0039 37.174.5 62.475.1 0.0078 12.472.5 13.771.7 0.8209
glis2 59.676.9 13.772.9 0.0078 30.474 75.973.2 0.0078 1073.5 10.472.8 0.2969
hat1 52.773.7 25.272.2 0.0078 27.874.7 56.171.9 0.0078 19.472.8 18.770.9 0.7422
lsm6 58.673.7 18.672.3 0.0078 25.373 62.573.5 0.0078 16.271.7 1972.3 0.25
mecp2 38.874.5 17.373.3 0.0078 48.473.8 68.273.4 0.0234 12.872.2 14.573.1 0.8438
mkrn2 50.277.3 20.574 0.0078 40.376.1 71.174.4 0.0078 9.573.5 8.472.2 0.8438
MGC81191/actn1 59.873.6 17.373 0.0039 2772.8 69.773.5 0.0039 13.372.4 1372.7 0.9102
mocs3 62.176.7 17.974 0.0039 27.174.9 7373.6 0.0039 10.873.6 9.171.5 0.6523
pura 57.177.4 23.173.1 0.0156 36.676.4 68.273.2 0.0156 6.472.7 8.772.3 0.4375
r3hdm2 6275.1 27.475.1 0.0078 28.274.8 55.774.3 0.0078 9.871.9 16.972 0.0156
rbfox2b 42.675.3 22.773.5 0.0391 47.875.7 6674.8 0.0195 9.671.8 11.373.1 0.7344
slc12a2 54.876.8 22.974.6 0.0039 27.974.7 62.975.2 0.0039 17.374.2 14.272.4 0.3594
tle1 4673.6 20.572.7 0.0078 43.973.2 70.873 0.0078 10.170.9 8.771.8 0.3125
vangl1 51.873.9 16.373.1 0.0156 32.174.4 7473.6 0.0156 16.172.5 9.771.1 0.1094
conMO group 2 43.273.5 21.673.3 o0.0001 39.873.4 56.575.6 o0.0001 1774.1 21.974.4 0.1973
cpeb1-a 32.374.5 17.574.4 0.0195 54.773.6 70.774.9 0.0078 1372.3 11.872.1 1
dio3 42.778.3 28.177.4 0.0313 42.676.7 51.975.8 0.1094 14.872.8 2073.1 0.1094
efna3 29.777.8 2773.9 0.6875 57.277.4 57.474 1 13.174.7 15.671.7 0.6875
eif3a 65.978.5 12.672.5 0.0078 20.676.2 71.973.1 0.0078 13.573.5 15.672.1 0.5469
elk4 2874.9 14.972 0.0029 47.474.8 60.874.8 0.0273 24.673.9 24.373.7 0.7646
ephB1 56.3711.6 26.174.6 0.0625 1676.4 50.975 0.0625 27.679 2374 0.8125
epx 36.973.6 18.673 0.0004 40.474.6 58.173.5 0.0023 22.773.5 23.473.3 0.9515
fmr1a 50.5711.5 20.375.5 0.0078 25.977.2 60.676.9 0.0078 23.677.5 1974.7 0.8125
fxr1a 36.177.9 21.476.1 0.0117 39.978.2 5876.4 0.0039 24.177.6 20.676.4 0.4375
gstp1 12.574.3 5.771.9 0.1563 74.274.4 85.572.3 0.0781 13.473.7 8.871.6 0.2188
hdac6 15.876.2 8.774.9 0.1563 61.776.9 71.579.2 0.1563 22.577.5 19.876.3 0.8438
hspa5 46.278.1 50.676.7 0.4688 45.376.4 36.974.1 0.2969 8.572.7 12.574.6 0.2188
mmp9 25.377.9 10.675.5 0.0313 56.777.3 73.278.3 0.1563 18.174 16.275.5 1
prkaca 2278.4 11.375.2 0.125 61.378.7 73.177 0.1563 16.773.2 15.673.4 1
wnt7b 46.974.7 34.877.9 0.3125 37.775.6 53.676.1 0.0625 15.473.3 11.575.3 0.2969
No morpholino 35.374.5 14.273.4 0.0017 45.773.5 6373.8 0.0017 1974.4 22.974.3 0.2163
conMO Combined 49.5 72.7 24.9 72.9 – 37.8 72.5 59.2 73.7 – 12.7 72.5 15.9 72.8 –
Tecta were electroporated with pSox2-bd::FP (either Kaede or tGFP) alone or combined with the control morpholino (conMO) or one of the 34 experimental morpholinos.
The proportions of each cell type were calculated on days 1 and 3 and the means, standard error of the mean (SEM) are given. Wilcoxon Signed Rank tests were used to
determine whether the proportions of the neural progenitor cells, neurons or unclassiﬁable cells changed signiﬁcantly between day 1 and day 3 p-values. Signiﬁcant
differences from control values are in bold.
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ditions would play a regulatory role in either maintaining NPCs in
a proliferative state or changing their fate to generate neurons. The
second microarray comparison was based on our in vivo studies
demonstrating that optic tectal neurons differentiate and integrate
into the functional visual circuit within 5 days (Bestman et al.,
2012; Chiu et al., 2008; Sharma and Cline, 2010). We therefore
compared transcripts from cells collected 1 or 5 days after labeling
to identify differentially expressed transcripts between NPCs and
differentiated neurons, similar to previous reports (Bhattacharya
et al., 2009; Carney et al., 2012; Falk et al., 2007; Geschwind and
Rakic, 2013; Karsten et al., 2003; Marei et al., 2011; Parker et al.,
2005). We then focused our attention on transcripts that were
differentially expressed in both sets of comparisons, based on the
idea that both comparisons would distinguish transcripts expres-
sed in NPCs from those expressed in neurons. The third microarray
comparison was based on observations that rates of proliferation
of Sox2-expressing NPCs decrease over development (Sharma and
Cline, 2010). We compared relatively active and quiescent NPCs
isolated from stage 47 and 49 tadpole optic tecta, anticipating that
the differential expression analysis would identify transcripts thatplay a role in maintaining NPCs in a proliferative or quiescent
state. We selected genes for follow up analysis by in vivo imaging
based on their fold-change values and p values in the microarray and
NanoString analyses. Some transcripts were chosen based on deduced
functions from the literature. Of the 27 differentially expressed tran-
scripts, morpholinos against 18 (66%) altered neurogenesis. Nano-
String identiﬁed 16 differentially-expressed transcripts, of which
morpholinos against 11 (69%) generated a neurogenesis phenotype.
Similarly, 65% (13/20) of differentially expressed transcripts identiﬁed
by microarrays had a neurogenic phenotype (Table 6).
Several bioinformatic analyses that we performed validated our
strategy to identify differentially expressed genes in NPCs and
neurons. All three microarray comparisons and the NanoString
analysis identiﬁed transcripts involved in processes governing cell
proliferation and differentiation. Of the 759 genes that were dif-
ferentially expressed in multiple microarray comparisons, 87%
(659) were enriched for either cell proliferation or cell differ-
entiation. These relationships are illustrated by the network gen-
erated by Gephi (Fig. 3A), which tightly clustered the aNPC tran-
script groups together. In each of the microarray comparisons
(Fig. 2B), and in the subset of transcripts that were upregulated
Table 5
Average proliferation rates between day 1 and day 3 with comparisons to control
values.
Morpholino Tectal
lobe #
Total
cell #
Cell prolifera-
tion rate
between day
1 and day 3
mean7SEM
Mann–
Whitney
Unpaired
p-values
% of control
cell prolifera-
tion rate
mean7SEM
conMO
Group 1
12 247 23.575.5 0.8052 100723.5
arl9 8 304 73.8715.4 0.005 314.8765.6
armc8 8 277 179.1749.8 0.003 763.97212.7
chn1 7 371 96.4 7 23.1 0.002 411.1798.5
ctdnep1 8 215 97.4726.9 0.006 415.57114.5
eif3a 8 300 40.978.1 0.097 174.4734.5
fbxw7 8 423 50.8718.4 0.202 216.4778.7
fgf2 9 407 64.779.4 0.002 275.9740.3
glis2 8 300 63.8715.4 0.012 271.6765.7
hat1 8 417 46.975.4 0.018 200723.1
lsm6 8 438 78.8716.3 0.005 336.4769.9
mecp2 8 288 4477.3 0.058 187.8731.3
MGC81191/
actn1
9 367 69.3715.1 0.006 295.7764.3
mkrn2 8 221 9.379.5 0.177 39.5740.5
mocs3 8 238 124.5731.1 0.002 531.37132.5
pura 8 232 48.1711.3 0.089 205748.2
r3hdm2 8 278 37.978.2 0.203 161.6734.9
rbfox2b 9 394 44.4721.1 0.722 189.3790
slc12a2 8 309 3176.4 0.396 132.1727.1
tle1 8 300 20.174.5 0.877 85.8719.3
vangl1 7 237 34.4721.8 0.704 146.5792.9
conMO
Group 2
11 296 20.874.1 0.8052 100719.8
cpeb1-a 10 157 6.273.8 0.029 29.5718.7
dio3 9 104 34.8714.4 0.676 167.3769.3
efna3 6 66 12.975.1 0.159 62.1724.7
elk4 11 322 37.778.04 0.048 181.7738.7
ephB1 5 91 115.6730.2 0.002 556.77145.5
epx 14 385 15.174.2 0.338 73.1720.4
fmr1-a 9 185 10.5711.2 0.033 47.8761.1
fxr1-a 10 101 3.2713.9 0.024 15.4766.8
gstp1 7 163 1.576.3 0.013 7.4730.7
hdac6 6 172 14.4713.5 0.291 68.8765.1
hspa5 7 121 2.6714.6 0.024 12.2770.2
mmp9 6 117 1.878.3 0.027 8.7739.8
prkaca 6 98 10.776.4 0.003 51.5730.7
wnt7b 8 119 11.2711.6 0.231 53.8756.1
noMO
Control
13 208 52.7714 0.118 253.7767.3
conMO
Combined
23 543 – 100715.15
Each control morpholino group (conMO group 1 and group 2) is compared to the
experimental MO data acquired over the same period (experimental results
grouped below each control group). All pSox2-bd::FP labeled cells in a tectal lobe
were counted on days 1 and 3 and the mean differences and standard error of the
mean (SEM) are given. The % of control levels7SEM is calculated by dividing the
proliferation rate of the experimental group by the mean control proliferation rate.
Mann–Whitney Unpaired tests were conducted for differences in the proliferation
rates to the control values and the p-values are given. Signiﬁcant differences from
control values are in bold. The "conMO Combined" value is the average averages of
all MO control values and is displayed in Figs. 7 and 8, but it is not used for sta-
tistical comparisons.
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analysis identiﬁed an abundance of transcripts associated with the
nucleosome and chromatin assembly. RNA binding proteins were
also signiﬁcantly higher in aNPCs. In addition, the analysis iden-
tiﬁed gene clusters that are associated with cellular metabolism
and oxygen transport, which are gene families that have known
functions in cell cycle control and differentiation (Mochizuki et al.,
2009). Analysis with MetaCore software showed that cell cycle and
cell fate pathways are up-regulated in aNPCs, consistent with theDAVID analysis. A range of cell cycle and cell fate pathways
are enriched in aNPCs, including transcripts involved in develop-
mental processes (e.g. notch and wnt signaling), the cell cycle (e.g.
cyclins and histones), and those that are involved in both the
immune response and cell proliferation (e.g. complement signaling
proteins).
Together, our analyses indicate that the strategy to enrich
populations of NPCs and differentiated neurons from intact brain
was successful. This approach identiﬁed known regulators of NPCs
and differentiating neurons (e.g., vimentin, Musashi1, Emx2, GLAST,
sox and pou transcription factors, neuroD, and HuC). Notably, the
bioinformatic analysis of the microarray data indicates that NPCs in
Xenopus optic tecta utilize a broad range of regulatory pathways in
neurogenesis. Furthermore, our in vivo analysis of neurogenesis in
animals treated with morpholinos indicates that a strategy of rapid
selection of candidate genes by differential gene expression com-
bined with sensitive in vivo morphogenetic assays effectively
identiﬁes candidate neurogenic genes for further study.
Activity-dependent regulation of neurogenesis
Growing evidence indicates that neural activity regulates NPC
proliferation and differentiation (LoTurco et al., 1995; Nacher and
McEwen, 2006; Reynolds et al., 2008), although the mechanisms
by which changes in neuronal circuit activity affect NPC pro-
liferation and differentiation remain unclear. Neuronal activity is
well known to induce hundreds of genes in neurons, many of
which play a role in synaptic plasticity, and some may indirectly
affect NPC functions. This study was designed to take advantage of
in vivo cellular interactions within a functional circuit that occur
with visual deprivation and developmental time to maximize
differences in NPC and neuronal populations in the harvested cell
groups. However, the differentially-expressed transcripts identi-
ﬁed in NPCs are not necessarily directly regulated by activity in
NPCs. We note that aNPCs from the different microarray compar-
isons share hundreds of upregulated transcripts, but aNPCs and
neurons share few differentially-expressed transcripts. Further
studies are required to determine how changes in sensory input
affect changes in gene expression in NPCs, and to determine how
candidate genes affect neurogenesis.
Differential contributions of cell proliferation and differentiation
to neurogenesis
Neurogenesis includes multiple distinct cellular events, each
regulated by distinct processes: cell proliferation, cell survival, and
differentiation. Our in vivo time-lapse imaging studies have shown
that optic tectal NPCs fall into several categories. A minority of
NPCs are either quiescent or symmetrically dividing; a majority of
NPCs divide asymmetrically and generate neurons (Bestman et al.,
2012). Many NPCs exhibit a protracted delay after cell division
before differentiating (Bestman et al., 2012), suggesting that NPCs
may respond to cues directing them to either exit the cell cycle and
differentiate or retain a progenitor fate. We anticipate that distinct
neurogenic regulatory genes affect these different cellular events.
Our analysis demonstrated that 24 of the 34 genes targeted with
morpholinos altered cell proliferation, and the majority of these also
changed the proportions of GFPþ neurons and NPCs. Among these
24 candidate neurogenic regulatory genes, we found a range of
outcomes with respect to cell fate and proliferative capacity (Fig. 10).
For example, morpholinos against gstp1 signiﬁcantly increased the
number of differentiated neurons and reduced the number of NPCs
compared to controls. This decreased total cell proliferation over the
imaging period, because the neural progenitor pool was depleted. In
contrast, morpholinos against hspa5 also limited total cell number,
but the proportion of NPCs increased and the proportion of neurons
Table 6
Summary of screening results from microarray, NanoString and in vivo imaging studies for genes examined by morpholino treatments. 0 means no signiﬁcant difference in the microarray, NanoString or in vivo analysis of
neurogenesis phenotypes. 1 means a signiﬁcant difference was detected in the assay(s) listed in the column. Concordance refers to the outcome detected in the microarray analysis comparing aNPC(vd) vs immature neurons and the
NanoString analysis. If concordance ¼ 1, the outcomes were the same. If concordance ¼0, the outcomes were different. Nd ¼ not determined.
Gene aNPCvd vs
immature
neuron
aNPC vs mature
neuron
aNPC vs qNPC Any array call Nano-String
call
Neuro-genesis
pheno-type
Array call and
neuro-genesis
pheno-type
Nano String call
and neuro-gen-
esis phenotype
Differential
expression by
nano String or
array
Differential
expression and
neuro-genesis
phenotype
Concordance
actn1/MGC81191 0 0 0 0 1 1 0 1 1 1 0
arl9 1 1 0 1 0 1 1 0 1 1 0
armc8 0 0 0 0 0 1 0 0 0 0 1
chn1 0 0 0 0 0 1 0 0 0 0 1
cpeb1-a 0 0 0 0 0 1 0 0 0 0 1
ctdnep1-a / Dullard 0 0 0 0 0 1 0 0 0 0 1
dio3 0 1 0 1 nd 1 1 0 1 1 nd
efna3 0 0 0 0 0 1 0 0 0 0 1
eif3a 1 1 0 1 0 1 1 0 1 1 0
elk4 0 1 1 1 1 1 1 1 1 1 0
ephb1 0 0 1 1 1 1 1 1 1 1 0
epx 1 1 1 1 1 0 0 0 1 0 1
fbxw7 1 1 0 1 nd 1 1 0 1 1 nd
fgf2 0 0 0 0 1 1 0 1 1 1 0
fmr1-a 0 0 0 0 1 1 0 1 1 1 0
fxrl-1 0 0 0 0 1 1 0 1 1 1 0
glis2 0 0 1 1 0 1 1 0 1 1 1
gstp1 1 1 1 1 nd 1 1 0 1 1 nd
hat1 0 1 0 1 1 1 1 1 1 1 0
hdac6 0 0 1 1 0 1 1 0 1 1 1
hspa5 0 1 1 1 0 1 1 0 1 1 1
ism6 0 1 0 1 1 1 1 1 1 1 0
mecp2 0 0 0 0 1 1 0 1 1 1 0
mkrn2 1 0 1 1 0 0 0 0 1 0 0
mmp9 1 1 1 1 nd 1 1 0 1 1 nd
mocs3 0 0 0 0 0 1 0 0 0 0 1
prkaca nd nd nd nd 1 1 nd 1 1 1 nd
pura 0 0 0 0 1 0 0 0 1 0 0
r3hdm2 0 0 1 1 1 0 0 0 1 0 0
rbfox2-b 0 0 0 0 0 0 0 0 0 0 1
slc12a2 0 0 0 0 1 0 0 0 1 0 0
tle1/tle2 1 0 0 1 1 0 0 0 1 0 1
vangl1 0 0 0 0 0 1 0 0 0 0 1
wnt7b 1 0 0 1 nd 0 0 0 1 0 0
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all candidate genes tested (34)
∆ cell proportions (20/34) 
∆ proliferation rate (19/34)
∆ neuronal # (3/34)
∆ progenitor # (5/34)
∆ proliferation rate & cell proportions (15/34)
∆ proliferation rate or cell proportions (24/34)
∆ proliferation rate & progenitor # (1/34)
Relationships between neurogenic phenotypes
Fig. 9. Candidate gene sets deﬁned by neurogenesis phenotypes. Categories of
neurogenesis phenotypes from morpholinos are shown as colored ellipses where
the area of each ellipse is proportional to the number of genes in that category. Of
the 34 candidate genes (red) tested with morpholino treatment, 24 signiﬁcantly
altered the proportions of cell types (blue circle, Pearson's Chi-square) and 19
signiﬁcantly altered the proliferation rate (yellow, Mann–Whitney U test). The
morpholinos against 15 candidate genes altered both the cell types generated and
the proliferation rate. The overlap between these two categories is shown in green.
Among these 15 genes, 5 generated signiﬁcant differences in the proportions of
NPCs (purple, Mann–Whitney U test) and of those, 3 also had signiﬁcant differences
in the number of neurons that were generated (light blue, Mann–Whitney U test).
One of the 5 (purple) changed both proliferation rate and NPC number (peach).
J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291284decreased, suggesting that hspa5 regulates neurogenesis by limiting
cell proliferation and decreasing differentiation. These examples
reﬂect three general mechanisms that control neurogenesis: the
regulation of progenitor proliferation, the regulation of cell cycle
exit, and the initiation of differentiation. It is also possible that
individual candidate genes affect several different cellular proce-
sses contributing to neurogenesis. For instance, we have recently
demonstrated that fxr1a, which encodes the Xenopus homolog of
FMRP, regulates neurogenesis by controlling both NPC survival and
neuronal differentiation (Faulkner et al., 2015). Finally, overlapping
cellular mechanisms may be affected by several of the genes tar-
geted in our study, as suggested below.
Candidates identify categories of cellular responses affecting
neurogenesis
Several candidate genes that were ﬁrst ﬂagged in the microarray
comparisons, and then shown to have a neurogenesis phenotype in
the in vivo imaging assays, play a role in regulating cytoskeletal
dynamics. For instance, histone deacetylase 6 (HDAC6), a cytoske-
letal scaffold protein expressed in both neural stem cells and neu-
rons (Valenzuela-Fernandez et al., 2008), is one of the candidates
identiﬁed and validated by our two-tiered screen. Following mor-
pholino treatment, hdac6morphant animals had signiﬁcantly fewer
GFP-labeled NPCs at all timepoints compared to control animals
(Tables 1 and 2), resulting in an overall decrease in cell proliferation
(Fig. 8A and Table 4). Unlike control animals, hdac6 morphants had
stable numbers of neurons and NPCs over the three days of in vivo
imaging (Table 3). HDAC6 may affect cell proliferation through
either its deacetylase activity or its ability to regulate protein ubi-
quitination and turnover. HDAC6 deacetylates several cytoskeletal
proteins, including tubulin, a major component of microtubules,
and cortactin, which regulates actin polymerization, suggesting that
HDAC6 may affect cell proliferation by regulating the microtubule-
based and actin-based cytoskeleton (Gao et al., 2007; Valenzuela-
Fernandez et al., 2008; Zhang et al., 2007). In neurons, HDAC6
regulates axon and dendrite outgrowth (Ageta-Ishihara et al., 2013;
Kim et al., 2009), neurodegeneration, and response to injury
(Rivieccio et al., 2009; Simoes-Pires et al., 2013), likely via its
capacity to regulate cytoskeletal dynamics and protein homeostasis.
Because electroporation distributes morpholinos throughout the
optic tectum, it is possible that morpholinos against hdac6 decrease
proliferation indirectly by modifying neuron or circuit function.
A second feature common to several of the candidates that we
tested is their potential role in protein homeostasis. As mentioned
above, HDAC6 contains an ubiquitin binding domain and may sta-
bilize polyubiquinated proteins (Valenzuela-Fernandez et al., 2008).
Similarly, ARMC8 is part of a highly conserved complex that regula-
tes protein degradation through both proteasomal/polyubiquitin-
dependent degradation and endocytosis of targets followed by
lysosome-mediated degradation (Tewari et al., 2010). Although
relatively little is known about ARMC8 function in NPCs and neu-
rons, evidence from other systems suggests it may bind micro-
tubules and thereby regulate microtubule dynamics and cell divi-
sion (Kobayashi et al., 2007; Tewari et al., 2010). HSPA5, also known
as BiP and GRP78, is an endoplasmic reticulum chaperone protein
that associates with newly synthesized proteins and facilitates
protein folding (Dudek et al., 2009; Zoghbi, 2005). HSPA5 is
involved in the unfolded protein response (UPR), an indicator of cell
stress in which aberrantly folded proteins are degraded. Recently,
HSPA5 has been implicated in Marinesco–Sjogren syndrome, a rare
inherited syndrome characterized by cerebellar ataxia and devel-
opmental delay (Anttonen et al., 2005; Inaguma et al., 2014; Sen-
derek et al., 2005; Zoghbi, 2005) characterized by defective cortical
neuron migration and axon growth. HSPA5 may also affect stem cell
proliferation and neurodegeneration (Fan, 2012; Paschen, 2003;Prinsloo et al., 2009). A fourth candidate that plays a role in protein
homeostasis is the detoxiﬁcation protein, GSTpi, encoded by gstp1.
GSTpi is the most highly expressed GST in the CNS, where it is
concentrated in neurogenic regions. Several studies suggest that
GSTpi plays a role in neurogenesis, through mechanisms indepen-
dent of its detoxiﬁcation functions (De Luca et al., 2003; Le Belle
et al., 2011; Walton et al., 2012). Neural stem cells have high
endogenous levels of reactive oxygen (ROS) and markers for oxi-
dative stress (Le Belle et al., 2011; Walton et al., 2012) and modest
increases in ROS may increase proliferation, while low ROS levels
correlate with NPC quiescence (Le Belle et al., 2011). The data sug-
gest that the energy-intensive process of cell division produces ROS
and induces expression of proteins that are classically considered
pathological stress proteins (Walton et al., 2012). We ﬁnd that the
GSTpi morpholino increase neuron numbers and deplete the pro-
genitor pool (Fig. 10). This is consistent with the idea that GSTpi and
ROS are dynamically regulated in the developing brain to control
speciﬁc cellular signaling pathways and functional outcomes
(Townsend et al., 2009; Walton et al., 2012).
Several candidates may affect neurogenesis through transcrip-
tional effects. For instance, ARMC8 regulates beta-catenin transac-
tivation and nuclear signaling indirectly by enhancing degradation
of its inactivating binding partner, alpha-catenin (Suzuki et al.,
2008). ARMC8 knockdown is therefore predicted to increase alpha-
catenin and increase proliferation (Stocker and Chenn, 2009).
Consistent with this, we observed an increase in neurogenesis with
the armc8 morpholino. ELK4, or ETS-like transcription factor, (a.k.a.
serum response factor accessory protein 1, SAP-1), belongs to a
family of transcription factors that is targeted by extracellular sig-
naling pathways and known as key regulators of neural develop-
mental events in a variety of species, including Xenopus (Janesick
et al., 2013; Remy and Baltzinger, 2000; Willardsen et al., 2014).
ELK4 may act as a transcriptional repressor or activator, depending
on post-translational modiﬁcation (Kaikkonen et al., 2010). In
addition, ELK4 has been shown to enhance expression of anti-
apoptotic proteins in glioma, thereby increasing proliferation (Day
et al., 2011). We ﬁnd that morpholinos against elk4 increased cell
proliferation by 182% of the control proliferation rate (Table 6). A
third candidate that may control neurogenesis through regulating
transcription is Glis2 (also known as NKL) (Hosking et al., 2007;
Lamar et al., 2001; Lichti-Kaiser et al., 2012). Glis2 can act as a
transcriptional activator or repressor, depending on its binding
partners (Hosking et al., 2007; Vasanth et al., 2011). Glis2 (in
Xenopus, mouse, and chick) is expressed in committed neural pro-
genitors and neurons (Lamar et al., 2001). Expressing Glis2 in
Xenopus and chick CNS promotes neuronal differentiation, likely by
control day 1 control day 3
armc8 day 1 armc8 day 3
gstp1 day 1 gstp1 day 1
hspa5 day 1 hspa5 day 3
or
or
rate of direct differentiation
rate & fate of cell cy
cle
Fig. 10. Summary of neurogenic outcomes under control conditions and with candidate gene morpholinos. (A) Diagram of NPC fates summarized from in vivo imaging
experiments. NPCs can either differentiate into neurons or divide and generate NPCs or neurons. (B) Cartoons of the proportions of NPCs and neurons observed on day 1 and
day 3 for control animals and animals electroporated with morpholinos against several candidate genes, which represent a range of neurogenic outcomes found in the
present study. In control animals, the proportion of NPCs decreases and the proportion of neurons increases over the observation period. Morpholinos against armc8 result in
an exaggerated increase in neurons, gstp1 morpholinos result in a rapid shift in the proportion of NPCs to neurons, whereas hspa5 morpholinos result in an increase in the
proportion of NPCs and a decrease in the proportion of neurons.
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(Lamar et al., 2001). Morpholinos against Glis2 increased the pro-
liferation rate by 272% of the control rate (Fig. 7A and Table 6),
consistent with a role in directing NPCs to exit the cell cycle.
The ﬁnal category of candidates includes extracellular pro-
teases, like matrix metalloprotease 9 (MMP9), a secreted Zinc-
dependent extracellular endopeptidase (Wlodarczyk et al., 2011).
MMP9 regulates the pericellular environment by local proteolysis
of speciﬁc substrates, including extracellular matrix (ECM) com-
ponents, beta-dystroglycan, beta 1 integrin, and neuroligins (Lee
et al., 2014; Michaluk et al., 2007; Peixoto et al., 2012; Wang et al.,
2008; Wlodarczyk et al., 2011). The ECM is thought to limitstructural dynamics of cells as well as extracellular signaling
capacity. We found that morpholinos against mmp9 stopped cell
proliferation, yielding no net increase in GFP-labeled cells over the
time lapse period. MMP9 plays a role in cell proliferation, neuronal
differentiation and plasticity, and neurodegeneration (Barkho
et al., 2008; Dziembowska et al., 2012; Kaplan et al., 2014; Marei
et al., 2011; Meighan et al., 2007; Nagy et al., 2006; Okulski et al.,
2007; Peixoto et al., 2012; Szklarczyk et al., 2002). It is interesting
to point out that MMP9 synthesis is increased in neurons down-
stream of NMDA receptor activity (Dziembowska et al., 2012), and
might affect NPCs in a non-cell autonomous manner.
J.E. Bestman et al. / Developmental Biology 408 (2015) 269–291286In conclusion, we have carried out a 2-tiered screen to identify
and validate candidate neurogenic genes based on a combinatorial
analysis of differential expression followed by a high content time-
lapse in vivo imaging protocol. That several candidates have
known roles in neurogenesis and brain development is evidence
that our strategy was capable of identifying neurogenic genes.
While here we used our gene proﬁling results to guide the selec-
tion of candidate genes, the in vivo imaging protocol could also be
used to understand the contributions of novel genes that are
identiﬁed through clinical genomics. We found that the genes we
identiﬁed participate in diverse cellular events and signaling
pathways, suggesting that our strategy was not biased toward
particular classes of genes or types of cellular signaling events. The
diversity of gene families and pathways identiﬁed in this study
also suggests that further analysis will identify more candidates
within the different pathways. Our data identiﬁed potentially
novel neurogenic regulators, demonstrating the utility of using
Xenopus as a vertebrate experimental system for gene discovery.
Finally, several candidate genes have been implicated in human
disease, suggesting that Xenopus will be a valuable experimental
system to probe mechanisms related to human brain health and
disease. Further studies are required to elucidate the mechanisms
by which speciﬁc candidates affect neurogenesis, for instance the
series of experiments described in our recent study that examined
the role of FMRP in neurogenesis (Faulkner et al., 2015).Materials and methods
Animal rearing
All animal protocols were approved by the Institutional Animal
Care and Use Committees of Cold Spring Harbor Laboratory
(approval # 05-02-04), The Marine Biological Laboratory at Woods
Hole, MA (approval # 08-07C), or the Scripps Research Institute at
La Jolla, CA, (approval # 08-0083). Fertilized eggs were acquired
from hormone-induced matings of albino X. laevis frogs in our
colony or purchased from commercial sources (Nasco, Fort
Atkinson, WI), Xenopus Express (Brooksville, FL), or Xenopus One
(Dexter, MI). Tadpoles were housed at 23 °C with a 12 h light: 12 h
dark diurnal cycle until used for experiments. Tadpoles were
anesthetized for in vivo experiments by placing them in 0.01%
MS-222 (Sigma; all chemicals were purchased from Sigma unless
noted), and terminally anesthetized in 0.2% MS-222 before brains
were dissected to harvest labeled cells (see below).
Animals used for microarray experiments were divided into
5 treatment groups. All animals were raised in 12 h Light: 12 h
Dark (L:D) conditions. At stage 46 (5 days post fertilization, dpf) or
stage 48 (10 dpf) (Nieuwkoop and Faber, 1956), tadpole optic tecta
were electroporated with pSox2-bd::tGFP. The pSox2-bd::FP
plasmid is described in detail in Bestman et al. (2012). Brieﬂy, the
Sox2/Oct3-4 transcription factor binding domain and FGF4 mini-
mal promoter were cloned upstream of gal4/UAS and a ﬂuorescent
protein (FP), in this case tGFP (Bestman et al., 2012). Tadpoles were
reared in one of three visual experience conditions: normal 12 h
light:12 h dark conditions; visual deprivation, in which animals
were placed in a dark chamber; or enhanced visual experience, in
which animals were placed in a chamber in which they received a
simulated motion stimulus from an array of LEDs (Sin et al., 2002).
Depending upon the experimental group, after either 1 or 5 days
under these conditions, the animals were anesthetized and tGFP-
positive cells were harvested manually, as described below. These
rearing conditions produced the 5 following cell groups: active
NPCs (aNPCs) isolated from the stage 46 animals one day after
electroporation; Mature Neurons isolated from the stage 46 tad-
poles 5 days after electroporation; Immature Neurons isolatedfrom stage 46 animals that were exposed to an enhanced visual
environment for the previous 24 h; aNPCvd isolated from st46
tadpoles that had been visually deprived for previous 24 h; and
qNPCs isolated from the stage 49 tadpoles 1 day after electro-
poration at stage 48.
Plasmid constructs and in vivo tectal cell transfection
DNA plasmids and morpholinos were electroporated into tectal
cells using bulk electroporation, a process by which macro-
molecules are injected into the tectal ventricle and driven into tectal
cells using voltage pulses across the midbrain (Sin et al., 2002). For
microarray studies, stage 46 or stage 48 tadpoles (Nieuwkoop and
Faber, 1956) were anesthetized and electroporated with 2 μg/μl
pSox2-bd::tGFP. For the in vivo imaging experiments, stage 46
tadpoles were anesthetized and co-electroporated with pSox2-bd::
FP plasmid and antisense morpholino oligonucleotides (described
below). The ﬂuorophores used in the pSox2-bd:FP plasmid for the
in vivo imaging experiments were turboGFP (Evrogen), a fast
maturing green ﬂuorescent protein, or Kaede (MBL International), a
ﬂuorophore whose emission can be irreversibly converted from
green to red ﬂuorescence after exposure to a UV light source. In
some experiments, we also co-electroporated the pSox2-bd:tur-
boGFP with pSox2-bd:turboRFPnls. TurboRFPnls is a fast maturing
red ﬂuorescent protein (Evrogen) tagged with a nuclear localization
sequence (nls) to label cell nuclei.
Microarray analysis
Harvesting GFP-expressing cells for RNA isolation/puriﬁcation
for microarray analysis
pSox2-bd::eGFP-expressing cells were harvested from 5 differ-
ent treatment groups of tadpoles, which differed according to their
developmental stage and visual experience rearing conditions, as
described above and in Fig. 1. Tadpoles were terminally anesthe-
tized in 0.2% MS-222 and their midbrains were dissected out
and placed in 1.5 ml microcentrifuge tubes containing 270 μl of
amphibian phosphate buffered saline (aPBS; 113 mM sodium
chloride, 8 mM sodium phosphate dibasic, 1.5 mM potassium
phosphate monobasic, pH 7.7) with 0.1% EDTA (Sigma). Once
8 midbrains were dissected, 30 μl of 2.5% Trypsin-EDTA (Invitro-
gen) was added to yield a ﬁnal working concentration of 0.25%
Trypsin-EDTA. After 15 min incubation at room temperature, the
reaction was stopped with 300 μl of Deﬁned Trypsin Inhibitor
(Invitrogen). The tissue was gently triturated with a large bore ﬁre-
polished glass Pasteur pipette and transferred into a 15 ml Falcon
tube containing 4 parts L15-Leibovitz medium (Invitrogen), 5 parts
APBS, and 1 part 10% Bovine Calf Serum (Invitrogen) in a total
volume of 10 ml. After 15 min on ice, the solution was triturated
again using a smaller bore ﬁre-polished glass Pasteur pipette. The
dissociated cell mixture was divided into 3 wells of a 4-well rec-
tangular cell culture plate (Nunc; well capacity 22 ml). The fourth
well of the plate contained media and served as the receptacle for
the harvested cells. The plate was placed on the stage of a Zeiss
Axiovert 200 microscope equipped with ﬂuorescence and an oil-
ﬁlled microinjector to hold a cell-picking micropipette mounted
on a 3-axis hydraulic micromanipulator (both, Narishige). Micro-
pipettes (1 mm outer diameter, 0.5 mm inner diameter glass, WPI)
were pulled using a Sutter P-97 puller, and scored with a light
swipe from a second micropipette so that they could be broken to
produce a clean, 50 μm diameter tip (Sutter Pipette Cookbook,
(Osterele, 2012). After the cells settled for 15 min in the culture
plate, eGFP-expressing cells were aspirated into the micropipette
and ejected into the 4th well of the plate, containing media. All
cells were collected within 90 min after the tissue was ﬁrst dis-
sociated with trypsin. The sorted cells were then pulled into a new
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trifuged gently to pellet the cells. Excess media was removed and
the samples were frozen at 80 °C. Typically, 8 tadpoles yielded
100–200 FP-positive cells. For each experimental condition, we
repeated the cell dissociation/harvesting procedure 12 times to
yield at least 1200 cells per condition.
RNA extraction, ampliﬁcation, preparation and hybridization
for microarray analysis
Harvested cells from each tadpole rearing condition were
pooled and then divided into 5 replicates that were prepared
simultaneously as follows. RNA was extracted using the PicoPure
RNA Isolation Kit (Applied Biosystems) and immediately ampliﬁed
using the WT-Ovation Pico Kit (NuGEN) according to manufac-
turer's instructions, except that we used 100% rather than 80%
ethanol during the RNA cleaning steps. The cDNA was fragmented
and labeled using the Encore Biotin Module (NuGEN). RNA quality
was analyzed before and after the ampliﬁcation with a Bioanalyzer
(Agilent). Labeled cDNA products were hybridized to the X. laevis
GeneChip 2.0 (Affymetrix) according to the NuGEN FL-Ovation
manual. Microarrays were rinsed and read using the methods
recommended by Affymetrix.
Microarray analysis
A GeneChip Scanner 3000 (Affymetrix) and GeneChip Command
Console and Expression Console Software (Affymetrix) were used to
read the microarray chips. Data were exported as CEL ﬁles by
Affymetrix Expression Console Software. Hybridization quality
across the chips was evaluated, and regions with edge effects or
bubbles were excluded from the analysis. Raw intensity data were
evaluated and processed by software developed by Tim Tully and
Philip Cheung (Dart Neuroscience LLC) as follows: (1) no back-
ground subtraction; (2) normalization using the geometric mean
across the whole gene chip to reduce the effect of uneven hybri-
dization across individual arrays; (3) data were subjected to a Box–
Cox transformation to normalize residuals (error variance) across
the replicates; (4) ﬁlter to exclude the individual probes affected by
the hybridization artifacts and outlier data points for single probes;
(5) data were subjected to a Box-Cox transformation after removing
ﬁltered probes to generate a more accurate transformation; (6) the
5 microarray replicates for each of the experimental conditions
were analyzed to derive gene expression values. Calls are made
based on either the p-value and/or powerT, which incorporates the
pooled variance of all 5 samples and reduced the false positive hit
(type I error).
We generated an updated version of the .CDF ﬁle (annotation
ﬁle matching the probes on the GeneChip to GeneBank mRNAs) to
incorporate the recent updates of the X. laevis genome data based
on work performed by the BrainArray group at the University of
Michigan (http://brainarray.mbni.med.umich.edu/Brainarray/Data
base/CustomCDF/genomic_curated_CDF.asp) (Dai et al., 2005). We
aligned the nucleotide sequence of each probe against the X. laevis
genome. Probes were removed from the analysis if they did not
match 100% to the X. laevis genome or if they matched more than
one transcript. In addition, in step 4 stated above, transcripts were
removed from the list of potential gene calls if the number of
probes identifying a transcript did not pass threshold. The updated
GeneChip annotation enabled us to screen for 7127 transcripts in
the X. laevis genome based on 105,838 probes. The numbers of
genes and probes we include in our analysis are different from the
Affymetrix-claimed 32,400 probe sets for 29,900 transcripts on the
GeneChip, because of updates to the X. laevis genome data. For the
arrays analyzed in the study, 7103–7115 transcripts per array
passed all the criteria for inclusion in the analysis. Transcripts that
exhibited differential expression between 2 rearing conditions,
were identiﬁed based on p-value o0.05 and Power T. We selected34 candidate genes for further validation using antisense mor-
pholino oligonucleotides (GeneTools, LLC) to inhibit their transla-
tion. Morpholinos were designed by GeneTools, and the sequences
for the experimental and control morpholinos used in the study
are given in Table 1
NanoString
Late stage 46 animals were electroporated with pSox2-bd::
turboGFP and reared in the dark (visual deprivation) or with
enhanced visual experience for 24 h to generate samples enriched
for aNPCvd and Immature Neurons, respectively. 100 midbrains
were collected from animals reared in each condition and dis-
sociated with aPBS. Approximately 40,000 Sox2þve-turboGFP
cells were collected using Fluorescence Activated Cell Sorting
(FACSAria II, BD Biosciences, USA). Total RNA was extracted fol-
lowing the mirVana miRNA kit protocol (Life Technologies, USA),
followed by DNase treatment to remove genomic DNA and clean-
up using RNeasy mini kit (Qiagen, USA). Total RNA had RIN 48,
measured with a Bioanalyser. 2ng of total RNA was ampliﬁed to
2–3 mg of double-stranded cDNA, using the Ovation RNA-Seq
System V2 (NuGEN, USA). The ampliﬁed cDNA was puriﬁed, using
Agencourt AMPure XP beads, quantiﬁed by NanoDrop, and its
quality was conﬁrmed with the Bioanalyser. 200 ng of cDNA was
used as input for the NanoString nCounter Gene Expression sys-
tem according to the manufacturer’s protocol. 4 biological repli-
cates were used for each condition.
The digital output of the number of transcripts was analyzed, using
nSolver Analysis Software 2.0. Background and hybridization were
normalized with spike-in negative and positive controls, provided by
the manufacturer; reference genes, GapdH (NM_001087098.1), actb
(NM_001088953.1), and rps13 (NM_001086882.1) were selected for
normalization between different biological replicates.
Welch's t-test was used to determine the signiﬁcance of dif-
ferential expression of each of the 95 transcripts between the
2 conditions in each replicate. A p-value o0.05 was required for
the transcripts to be called as signiﬁcantly different between the
2 conditions.
Concordance analysis was performed among 4 replicates to
determine whether the transcript expression levels were statisti-
cally different between the aNPCvd and Immature Neuron samples
based on the following criteria: if 4 out of 4 replicates have p-value
o0.05, and 3–4 replicates show differential expression in the
same direction, or if 2–3 replicates out of 4 have p-value o0.05,
and all 4 show differential expression in the same direction.
Otherwise, the expression level of transcripts was considered non-
signiﬁcant.
Bioinformatic analysis
The gene networks were plotted using the Gephi program
(version 0.8.2; Bastian et al., 2009) using the Force Atlas layout
with the following parameters to generate a stable gene network:
0.1 attraction strength, 0.2 auto stabilize function, 10000 autostab
strength, 30 gravity, 10000 maximum displacement, 10,0000
repulsion strength, adjusted by sizes and attraction distribution.
Pathway analyses were performed with DAVID, the Database for
Annotation, Visualization and Integrated Discovery (http://david.
abcc.ncifcrf.gov; (Huang et al., 2009) and MetaCore (Thomson
Reuters, NY) to investigate the biological and functional implica-
tions of the differentially-regulated gene expression seen in the
different rearing conditions. DAVID was used to compare the fre-
quency of gene ontology terms in a transcript list to the expected
frequency of the background. The transcripts from the Affymetrix
X. laevis 2.0 chips were used as the background. We set DAVID
EASE Scores (a modiﬁed Fisher exact p-value) to po0.05, and used
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genes with Benjamini false discovery rates of po0.05.
MetaCore (Thomson Reuters Ltd.; http://www.genego.com/
metacore.php) mines a privately curated integrated knowledge
database and is designed for pathway analysis of human gene lists.
Human homologs of the X. laevis transcripts identiﬁed by search-
ing oligonucleotides on the Afﬁmetrix 2.0 Xenopus microarray
were used as input for MetaCore. MetaCore maps the input genes
in a list onto genes in the built-in functional ontologies, such as
pathway maps and map folders, and networks, and ranks the map
folders or pathway maps based on their p-values of hypergeo-
metric distribution. The p-value is calculated as the probability of a
particular mapping of a list to an ontology compared to chance,
considering the size of the ontology and the gene list from the
comparison. p-value o0.05 was used as the cut-off to ensure the
non-randomness of the selected entities in any given ontology. In
addition to p-value, a False Discovery Rate (FDR) o0.05 was also
applied to minimize the occurrence of type I errors in the multiple
comparisons. Two major ontologies were used to describe the
differentially expressed genes from three comparisons, map fold-
ers and canonical pathway maps. Map folders are a collection of
pathway maps, grouped hierarchically into folders based on the
main biological processes. Canonical pathway maps have multiple
sequential steps of interactions, deﬁning a signaling mechanism.
Map folders provide an overview on the major biological processes
of the genes of interest from each comparison list. Canonical
pathway maps provide detailed information on the cascades in the
signaling mechanism. In addition, individual canonical pathway
maps can be ranked independently of the hierarchical ranking of
the map folders, in which they are categorized. These two different
ontologies provide insights into the biological processes of the
genes enriched in either cell proliferation or differentiation.
In vivo time-lapse imaging and data analysis
We selected 34 candidate genes for analysis of their roles in cell
proliferation and neuronal differentiation (Table 1). Of these 27/34
showed differential expression by microarray or NanoString ana-
lysis (Table 6). The remaining morpholinos were included in the
candidate list based on predicted effects on neurogenesis from the
literature or based on initial microarray comparisons, which sub-
sequent analysis using an updated CDF ﬁle and more stringent
inclusion criteria suggested were not differentially expressed.
Morpholinos initially designed against elk4 or elk4-b were subse-
quently predicted to interact with both transcripts.
To prepare animals for in vivo time-lapse imaging, stage 46
tadpoles were bulk electroporated with 0.1 mM antisense mor-
pholino oligonucleotide (GeneTools, Philomath, OR) and 2 μg/μl
pSox2-bd::FP (where FP was Kaede or turboGFP) alone or com-
bined with pSox2-bd::turboRFPnls. Morpholinos were resuspended
in water to make 1 mM stock solutions that were diluted to
0.1 mM working concentrations. Animals were returned to normal
rearing conditions after electroporation and time-lapse imaging
protocols began 24–36 h later when the tadpoles were stage 47.
For imaging, tadpoles were anesthetized in 0.01% MS-222 and
placed in a custom-built chamber with a coverslip placed in con-
tact with the skin directly over the brain. We monitored blood
ﬂow in the CNS to ensure the animals were healthy. Tadpoles with
approximately 20 sparsely labeled cells per optic tectal lobe were
selected for time-lapse imaging. Complete 3D confocal stacks
(180 μm depth at 1 μm intervals) of all labeled cells in the tectum
were acquired once a day over 3 days, with an Ultraview VoX,
Yokogawa spinning disk confocal system (Perkin-Elmer), as
described (Bestman et al., 2012). After each imaging session, tad-
poles were placed in Steinberg's solution in a 6-well tissue culture
dish and returned to normal 12 h light: 12 h dark conditions.We used the automated functions of Volocity 5 software
(Improvision/Perkin Elmer) to identify and count cells in the 3D
confocal stacks, and veriﬁed results of automated analysis by
visual inspection. Analysis was also conducted using the FIJI ima-
ging processing package of Image J (Schindelin et al., 2012;
Schneider et al., 2012), in which FP-labeled cells were identiﬁed
and counted. The numbers of FP-expressing cells at day 1 and day
3 were counted and the proliferation rates were calculated as the
change in FP-expressing cell numbers between day 3 and day 1,
normalized to the number of labeled cells on day 1. In addition,
each cell was assigned an identity based on its morphological
features described previously (Bestman et al., 2012; Wu and Cline,
2003; Wu et al., 1999). To summarize, we designated the cell as a
neural progenitor cell when it had a radial process that ended on
the pial surface with endfoot enlargement. Neural progenitors lack
axons or dendritic arbors characteristic of neurons. Young neurons
with few branches are distinguished from neural progenitors by
the outgrowth of axons along the surface of the tectum. These data
were used to determine the proportion of neurons and neural
progenitors present in the ﬁnal image for each experimental
condition.
The time-lapse imaging experiments were conducted in two
blocks at the Marine Biological Laboratory and The Scripps
Research Institute. Imaging data using the control morpholinos
were comparable between the 2 blocks of experiments, with
respect to the proliferation rate over 48 h (23.5%75.5 and
20.874.1%; p¼0.12, Mann–Whitney U test) and the proportions of
neurons, radial glia and unidentiﬁable cell types (Pearson's Chi-
square test, p¼0.06). Nevertheless, the experimental datasets
were compared to the corresponding control data collected during
the same period. The experimental data and the corresponding
control data for each block of experiments are provided in
Tables 3–5. The control data shown in Figs. 7A4–5 and 8 are
combined from both sets.
Morpholinos injected into early stage Zebraﬁsh embryos can
result in off target effects and apoptosis by activating p53, although
the mechanisms underlying p53 activation remain unclear (Robu
et al., 2007). Our in vivo imaging in this and previous studies indicate
that targeted electroporation of control or experimental morpholinos
into the optic tectum produce a variety of phenotypes with respect to
neurogenesis and synaptic plasticity (Bestman and Cline, 2008; Chiu
et al., 2008; Ewald et al., 2008; Sharma and Cline, 2010; Shen et al.,
2009; Shen et al., 2014) and do not appear to damage cells. This
could be due to more targeted delivery of morpholinos, differences in
morpholino concentrations in cells or incomplete knockdown in our
studies, or greater sensitivity of early developmental events to off
target p53 activation in Zebraﬁsh. In addition, we have previously
demonstrated that MO treatments can be replicated by dominant
negative constructs (Chiu et al., 2008) and that titration of mor-
pholino-insensitive expression constructs can rescue phenotypes
seen with morpholino treatment (Faulkner et al., 2015). A recent
report suggests that Zebraﬁsh morphant embryos and genetic
knockdown by site-speciﬁc nucleases do not produce comparable
outcomes, based on assays of vascular development (Kok et al., 2015;
Stainier et al., 2015). The phenotypic differences between site-spe-
ciﬁc nucleases and morpholino-mediated knockdown could be due
to a variety of as yet unconﬁrmed but biologically interesting effects,
such as hypomorphic effects due to exon skipping, compensation by
family members, or different degrees of knockdown in the morphant
and mutant ﬁsh (Stainier et al., 2015). Nevertheless, our study was
designed as a screen for candidate neurogenic regulatory genes and
candidates must be further evaluated with a battery of mechanistic
studies. The studies mentioned above in Zebraﬁsh emphasize the
importance of follow up analysis, including a full range of gene and
protein expression manipulations, as we describe in our analysis of
fmr1a in neurogenesis (Faulkner et al., 2015).
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Pearson's Chi-square test was used to determine whether there
were signiﬁcant differences in the proportions of cell types gen-
erated between control MO conditions and experimental MO
conditions. When signiﬁcant differences were detected, we used a
Mann–Whitney Unpaired test to determine which cell types
(neurons, neural progenitors or unclassiﬁed cells) were different
signiﬁcantly between the groups. Mann–Whitney Unpaired tests
were also used to identify signiﬁcant differences in the prolifera-
tion rates between experimental groups and the control Mor-
pholino conditions. pr0.05 were considered signiﬁcant. Wilcoxon
Signed Rank tests were used to detect pairwise changes in the cells
types identiﬁed at day one and day 3. Graphs show means 7
standard error of the mean. All values for data summarized in the
ﬁgures are presented in Tables 3–6.Acknowledgments
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